
The following have been reloaded with a version change:
  1) GCCcore/8.3.0 => GCCcore/9.3.0
  2) binutils/2.32-GCCcore-8.3.0 => binutils/2.34-GCCcore-9.3.0
  3) zlib/1.2.11-GCCcore-8.3.0 => zlib/1.2.11-GCCcore-9.3.0

2021-02-01 01:04:54 | INFO | fairseq_cli.train | Namespace(activation_dropout=0.0, activation_fn='relu', adam_betas='(0.9, 0.98)', adam_eps=1e-08, adaptive_input=False, adaptive_softmax_cutoff=None, adaptive_softmax_dropout=0, all_gather_list_size=16384, arch='transformer_vaswani_wmt_en_de_big', attention_dropout=0.0, best_checkpoint_metric='loss', bf16=False, bpe=None, broadcast_buffers=False, bucket_cap_mb=25, checkpoint_suffix='', clip_norm=0.0, cpu=False, criterion='label_smoothed_cross_entropy', cross_self_attention=False, curriculum=0, data='../../../data-bin/phrase_4_0.5_tag_EMEA', data_buffer_size=10, dataset_impl=None, ddp_backend='c10d', decoder_attention_heads=16, decoder_embed_dim=1024, decoder_embed_path=None, decoder_ffn_embed_dim=4096, decoder_input_dim=1024, decoder_layerdrop=0, decoder_layers=6, decoder_layers_to_keep=None, decoder_learned_pos=False, decoder_normalize_before=False, decoder_output_dim=1024, device_id=0, disable_validation=False, distributed_backend='nccl', distributed_init_method=None, distributed_no_spawn=False, distributed_port=-1, distributed_rank=0, distributed_world_size=1, distributed_wrapper='DDP', dropout=0.2, empty_cache_freq=0, encoder_attention_heads=16, encoder_embed_dim=1024, encoder_embed_path=None, encoder_ffn_embed_dim=8192, encoder_layerdrop=0, encoder_layers=6, encoder_layers_to_keep=None, encoder_learned_pos=False, encoder_normalize_before=False, eval_bleu=True, eval_bleu_args='{"beam": 5, "max_len_a": 1.2, "max_len_b": 10}', eval_bleu_detok='moses', eval_bleu_detok_args=None, eval_bleu_print_samples=True, eval_bleu_remove_bpe='@@ ', eval_tokenized_bleu=False, fast_stat_sync=False, find_unused_parameters=False, fix_batches_to_gpus=False, fixed_validation_seed=None, fp16=True, fp16_init_scale=128, fp16_no_flatten_grads=False, fp16_scale_tolerance=0.0, fp16_scale_window=None, keep_best_checkpoints=-1, keep_interval_updates=-1, keep_last_epochs=-1, label_smoothing=0.1, layernorm_embedding=False, left_pad_source='True', left_pad_target='False', load_alignments=False, localsgd_frequency=3, log_format=None, log_interval=100, lr=[0.000175], lr_scheduler='inverse_sqrt', max_epoch=20, max_sentences=None, max_sentences_valid=None, max_source_positions=1024, max_target_positions=1024, max_tokens=1024, max_tokens_valid=1024, max_update=0, maximize_best_checkpoint_metric=False, memory_efficient_bf16=False, memory_efficient_fp16=False, min_loss_scale=0.0001, min_lr=-1, model_parallel_size=1, no_cross_attention=False, no_epoch_checkpoints=True, no_last_checkpoints=False, no_progress_bar=False, no_save=False, no_save_optimizer_state=False, no_scale_embedding=False, no_seed_provided=True, no_token_positional_embeddings=False, nprocs_per_node=1, num_batch_buckets=0, num_workers=1, optimizer='adam', optimizer_overrides='{}', patience=-1, profile=False, quant_noise_pq=0, quant_noise_pq_block_size=8, quant_noise_scalar=0, quantization_config_path=None, required_batch_size_multiple=8, reset_dataloader=True, reset_lr_scheduler=False, reset_meters=False, reset_optimizer=True, restore_file='../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt', save_dir='../checkpoints/EMEA_p_8', save_interval=1, save_interval_updates=0, scoring='bleu', seed=1, sentence_avg=False, share_all_embeddings=False, share_decoder_input_output_embed=True, skip_invalid_size_inputs_valid_test=False, slowmo_algorithm='LocalSGD', slowmo_momentum=None, source_lang=None, stop_time_hours=0, target_lang=None, task='translation', tensorboard_logdir='', threshold_loss_scale=None, tie_adaptive_weights=False, tokenizer=None, tpu=False, train_subset='train', truncate_source=False, update_freq=[1], upsample_primary=1, use_bmuf=False, use_old_adam=False, user_dir=None, valid_subset='valid', validate_after_updates=0, validate_interval=1, validate_interval_updates=0, warmup_init_lr=-1, warmup_updates=4000, weight_decay=1e-07)
2021-02-01 01:04:54 | INFO | fairseq.tasks.translation | [de] dictionary: 42024 types
2021-02-01 01:04:54 | INFO | fairseq.tasks.translation | [en] dictionary: 42024 types
2021-02-01 01:04:54 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/valid.de-en.de
2021-02-01 01:04:54 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/valid.de-en.en
2021-02-01 01:04:54 | INFO | fairseq.tasks.translation | ../../../data-bin/phrase_4_0.5_tag_EMEA valid de-en 151 examples
2021-02-01 01:05:00 | INFO | fairseq_cli.train | TransformerModel(
  (encoder): TransformerEncoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
  )
  (decoder): TransformerDecoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
    (output_projection): Linear(in_features=1024, out_features=42024, bias=False)
  )
)
2021-02-01 01:05:00 | INFO | fairseq_cli.train | model transformer_vaswani_wmt_en_de_big, criterion LabelSmoothedCrossEntropyCriterion
2021-02-01 01:05:00 | INFO | fairseq_cli.train | num. model params: 312778752 (num. trained: 312778752)
2021-02-01 01:05:10 | INFO | fairseq.trainer | detected shared parameter: decoder.embed_tokens.weight <- decoder.output_projection.weight
2021-02-01 01:05:10 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-02-01 01:05:10 | INFO | fairseq.utils | rank   0: capabilities =  7.0  ; total memory = 32.000 GB ; name = GRID V100D-32Q                          
2021-02-01 01:05:10 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-02-01 01:05:10 | INFO | fairseq_cli.train | training on 1 devices (GPUs/TPUs)
2021-02-01 01:05:10 | INFO | fairseq_cli.train | max tokens per GPU = 1024 and max sentences per GPU = None
2021-02-01 01:05:14 | INFO | fairseq.trainer | loaded checkpoint ../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt (epoch 16 @ 0 updates)
2021-02-01 01:05:14 | INFO | fairseq.trainer | loading train data for epoch 1
2021-02-01 01:05:14 | INFO | fairseq.data.data_utils | loaded 93981 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/train.de-en.de
2021-02-01 01:05:14 | INFO | fairseq.data.data_utils | loaded 93981 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/train.de-en.en
2021-02-01 01:05:14 | INFO | fairseq.tasks.translation | ../../../data-bin/phrase_4_0.5_tag_EMEA train de-en 93981 examples
2021-02-01 01:05:17 | INFO | fairseq_cli.train | begin training epoch 1
2021-02-01 01:05:18 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 64.0
2021-02-01 01:05:18 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 32.0
2021-02-01 01:05:18 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 16.0
2021-02-01 01:05:18 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 8.0
2021-02-01 01:05:28 | INFO | train_inner | epoch 001:    104 / 1334 loss=3.153, nll_loss=1.377, ppl=2.6, wps=9340.8, ups=9.88, wpb=945.8, bsz=70.2, num_updates=100, lr=4.375e-06, gnorm=12.283, loss_scale=8, train_wall=10, wall=18
2021-02-01 01:05:38 | INFO | train_inner | epoch 001:    204 / 1334 loss=2.637, nll_loss=0.821, ppl=1.77, wps=9258.2, ups=10.04, wpb=922.4, bsz=69.1, num_updates=200, lr=8.75e-06, gnorm=2.804, loss_scale=8, train_wall=10, wall=28
2021-02-01 01:05:48 | INFO | train_inner | epoch 001:    304 / 1334 loss=2.406, nll_loss=0.574, ppl=1.49, wps=9337.5, ups=9.99, wpb=934.5, bsz=71.8, num_updates=300, lr=1.3125e-05, gnorm=1.7, loss_scale=8, train_wall=10, wall=38
2021-02-01 01:05:58 | INFO | train_inner | epoch 001:    404 / 1334 loss=2.398, nll_loss=0.567, ppl=1.48, wps=9341.8, ups=10.05, wpb=929.9, bsz=69.4, num_updates=400, lr=1.75e-05, gnorm=1.672, loss_scale=8, train_wall=10, wall=48
2021-02-01 01:06:08 | INFO | train_inner | epoch 001:    504 / 1334 loss=2.344, nll_loss=0.512, ppl=1.43, wps=9317.4, ups=10.02, wpb=929.9, bsz=71.6, num_updates=500, lr=2.1875e-05, gnorm=1.444, loss_scale=8, train_wall=10, wall=58
2021-02-01 01:06:18 | INFO | train_inner | epoch 001:    604 / 1334 loss=2.282, nll_loss=0.441, ppl=1.36, wps=9337.7, ups=9.93, wpb=940.5, bsz=71.2, num_updates=600, lr=2.625e-05, gnorm=1.464, loss_scale=8, train_wall=10, wall=68
2021-02-01 01:06:28 | INFO | train_inner | epoch 001:    704 / 1334 loss=2.274, nll_loss=0.437, ppl=1.35, wps=9317.3, ups=10.05, wpb=927.1, bsz=71.4, num_updates=700, lr=3.0625e-05, gnorm=1.367, loss_scale=8, train_wall=10, wall=78
2021-02-01 01:06:38 | INFO | train_inner | epoch 001:    804 / 1334 loss=2.332, nll_loss=0.499, ppl=1.41, wps=9269.2, ups=10.04, wpb=923.5, bsz=68.8, num_updates=800, lr=3.5e-05, gnorm=1.346, loss_scale=8, train_wall=10, wall=88
2021-02-01 01:06:48 | INFO | train_inner | epoch 001:    904 / 1334 loss=2.213, nll_loss=0.37, ppl=1.29, wps=9511.1, ups=10.01, wpb=950.4, bsz=73.4, num_updates=900, lr=3.9375e-05, gnorm=1.014, loss_scale=8, train_wall=10, wall=98
2021-02-01 01:06:58 | INFO | train_inner | epoch 001:   1004 / 1334 loss=2.269, nll_loss=0.432, ppl=1.35, wps=9264.6, ups=10.03, wpb=923.3, bsz=71.4, num_updates=1000, lr=4.375e-05, gnorm=1.23, loss_scale=8, train_wall=10, wall=108
2021-02-01 01:07:08 | INFO | train_inner | epoch 001:   1104 / 1334 loss=2.246, nll_loss=0.405, ppl=1.32, wps=9308.1, ups=10.01, wpb=929.7, bsz=69.5, num_updates=1100, lr=4.8125e-05, gnorm=1.203, loss_scale=8, train_wall=10, wall=118
2021-02-01 01:07:18 | INFO | train_inner | epoch 001:   1204 / 1334 loss=2.209, nll_loss=0.364, ppl=1.29, wps=9373.4, ups=9.99, wpb=938.3, bsz=69.8, num_updates=1200, lr=5.25e-05, gnorm=1.061, loss_scale=8, train_wall=10, wall=128
2021-02-01 01:07:28 | INFO | train_inner | epoch 001:   1304 / 1334 loss=2.224, nll_loss=0.38, ppl=1.3, wps=9220.5, ups=9.97, wpb=925.1, bsz=68.3, num_updates=1300, lr=5.6875e-05, gnorm=1.174, loss_scale=8, train_wall=10, wall=138
2021-02-01 01:07:31 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:07:34 | INFO | fairseq.tasks.translation | example hypothesis: Vials 5 x (1 x 10 ml) 1
2021-02-01 01:07:34 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:07:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP In these cases, consideration should be given to the advisability of driving.
2021-02-01 01:07:34 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:07:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:07:35 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:07:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP The doctor must therefore take into account possible interactions during therapy and always ask his patients about other medicinal products they are taking.
2021-02-01 01:07:35 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:07:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Subcutaneous injection into the abdominal wall results in faster absorption than other injection sites.
2021-02-01 01:07:36 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:07:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP If the patient does not respond to glucose administration within 10 to 15 minutes, a glucose solution must be administered intravenously.
2021-02-01 01:07:37 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:07:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Use Subcutaneous or intravenous administration. Actrapide can also be administered intravenously, this should only be done by healthcare professionals.
2021-02-01 01:07:38 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:07:39 | INFO | fairseq.tasks.translation | example hypothesis: As with any insulin therapy, reactions can occur at the injection site, such as pain, itching, hives, swelling and inflammation.
2021-02-01 01:07:39 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:07:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with symptoms that are known as acute painful neuropathy and are usually reversible.
2021-02-01 01:07:40 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:07:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP The first symptoms of hyperglycaemia, such as thirst, increased urination, nausea, vomiting, drowsiness, dry red skin, dry mouth, thirst UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP and acetone UNKNOWNTOKENINHYP smelling UNKNOWNTOKENINHYP breath, usually occur gradually over hours or days.
2021-02-01 01:07:41 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:07:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Light hypoglycaemia can be treated by oral administration of glucose or sugary foods. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Diabetics should therefore always carry glucose, sweets, biscuits or sugary fruit juice. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Severe hypoglycaemia with unconsciousness UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:07:43 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:07:46 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body cannot process insulin effectively (one trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is UNKNOWNTOKENINHYP -controlled. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid shown in these trials UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during the UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP -month UNKNOWNTOKENINHYP treatment with actrapid.
2021-02-01 01:07:46 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:07:46 | INFO | valid | epoch 001 | valid on 'valid' subset | loss 3.813 | nll_loss 2.111 | ppl 4.32 | bleu 37.19 | wps 337.1 | wpb 361 | bsz 12.6 | num_updates 1330
2021-02-01 01:07:46 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:08:16 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_best.pt (epoch 1 @ 1330 updates, score 3.813) (writing took 30.627252615988255 seconds)
2021-02-01 01:08:16 | INFO | fairseq_cli.train | end of epoch 1 (average epoch stats below)
2021-02-01 01:08:16 | INFO | train | epoch 001 | loss 2.38 | nll_loss 0.549 | ppl 1.46 | wps 6940.9 | ups 7.44 | wpb 932.4 | bsz 70.4 | num_updates 1330 | lr 5.81875e-05 | gnorm 2.269 | loss_scale 8 | train_wall 132 | wall 186
2021-02-01 01:08:16 | INFO | fairseq_cli.train | begin training epoch 1
2021-02-01 01:08:24 | INFO | train_inner | epoch 002:     70 / 1334 loss=2.179, nll_loss=0.331, ppl=1.26, wps=1683.4, ups=1.8, wpb=937.6, bsz=71.9, num_updates=1400, lr=6.125e-05, gnorm=1.053, loss_scale=8, train_wall=10, wall=193
2021-02-01 01:08:34 | INFO | train_inner | epoch 002:    170 / 1334 loss=2.159, nll_loss=0.311, ppl=1.24, wps=9203.3, ups=9.95, wpb=925.4, bsz=71.7, num_updates=1500, lr=6.5625e-05, gnorm=0.981, loss_scale=8, train_wall=10, wall=204
2021-02-01 01:08:44 | INFO | train_inner | epoch 002:    270 / 1334 loss=2.178, nll_loss=0.329, ppl=1.26, wps=9309, ups=9.99, wpb=931.6, bsz=70.9, num_updates=1600, lr=7e-05, gnorm=1.1, loss_scale=8, train_wall=10, wall=214
2021-02-01 01:08:54 | INFO | train_inner | epoch 002:    370 / 1334 loss=2.167, nll_loss=0.319, ppl=1.25, wps=9285.1, ups=10.01, wpb=927.2, bsz=70.4, num_updates=1700, lr=7.4375e-05, gnorm=1.027, loss_scale=8, train_wall=10, wall=224
2021-02-01 01:09:04 | INFO | train_inner | epoch 002:    470 / 1334 loss=2.178, nll_loss=0.329, ppl=1.26, wps=9363.2, ups=9.94, wpb=942.1, bsz=70.4, num_updates=1800, lr=7.875e-05, gnorm=1.014, loss_scale=8, train_wall=10, wall=234
2021-02-01 01:09:14 | INFO | train_inner | epoch 002:    570 / 1334 loss=2.169, nll_loss=0.319, ppl=1.25, wps=9228.6, ups=9.94, wpb=928.8, bsz=68.9, num_updates=1900, lr=8.3125e-05, gnorm=1.037, loss_scale=8, train_wall=10, wall=244
2021-02-01 01:09:24 | INFO | train_inner | epoch 002:    670 / 1334 loss=2.173, nll_loss=0.325, ppl=1.25, wps=9300.9, ups=10, wpb=929.9, bsz=68.2, num_updates=2000, lr=8.75e-05, gnorm=0.991, loss_scale=8, train_wall=10, wall=254
2021-02-01 01:09:34 | INFO | train_inner | epoch 002:    770 / 1334 loss=2.14, nll_loss=0.288, ppl=1.22, wps=9399.1, ups=9.98, wpb=941.9, bsz=70, num_updates=2100, lr=9.1875e-05, gnorm=0.948, loss_scale=8, train_wall=10, wall=264
2021-02-01 01:09:44 | INFO | train_inner | epoch 002:    870 / 1334 loss=2.172, nll_loss=0.326, ppl=1.25, wps=9244.1, ups=10.01, wpb=923.4, bsz=70.4, num_updates=2200, lr=9.625e-05, gnorm=0.995, loss_scale=8, train_wall=10, wall=274
2021-02-01 01:09:54 | INFO | train_inner | epoch 002:    970 / 1334 loss=2.147, nll_loss=0.297, ppl=1.23, wps=9326.5, ups=10.05, wpb=927.9, bsz=71, num_updates=2300, lr=0.000100625, gnorm=0.866, loss_scale=8, train_wall=10, wall=284
2021-02-01 01:10:04 | INFO | train_inner | epoch 002:   1070 / 1334 loss=2.148, nll_loss=0.299, ppl=1.23, wps=9447.8, ups=10.02, wpb=942.9, bsz=72.5, num_updates=2400, lr=0.000105, gnorm=0.961, loss_scale=8, train_wall=10, wall=294
2021-02-01 01:10:14 | INFO | train_inner | epoch 002:   1170 / 1334 loss=2.149, nll_loss=0.298, ppl=1.23, wps=9402.6, ups=10.07, wpb=933.7, bsz=69.6, num_updates=2500, lr=0.000109375, gnorm=0.987, loss_scale=8, train_wall=10, wall=304
2021-02-01 01:10:24 | INFO | train_inner | epoch 002:   1270 / 1334 loss=2.147, nll_loss=0.296, ppl=1.23, wps=9282.3, ups=10.03, wpb=925.4, bsz=70, num_updates=2600, lr=0.00011375, gnorm=1.005, loss_scale=8, train_wall=10, wall=314
2021-02-01 01:10:30 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:10:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP vials 5 x (1 x 10 ml) 1 UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:10:31 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:10:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP In these cases, consideration should be given whether driving UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:10:31 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:10:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide 40 IU/ ml.
2021-02-01 01:10:32 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:10:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP The physician must therefore take into account possible interactions during therapy and must always ask his patients about other medicinal products they take. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:10:33 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:10:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Subcutaneous injection into the abdominal wall UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Subcutaneous injection into the abdominal wall UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PRODUCT UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:10:33 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:10:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP If the patient does not respond to the glucagonist solution within 10 to 15 minutes, a glucose solution UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP.
2021-02-01 01:10:34 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:10:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP For subcutaneous or intravenous use. Actrapide may also be administered intravenously, but only by medical staff. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Use
2021-02-01 01:10:35 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:10:36 | INFO | fairseq.tasks.translation | example hypothesis: As with any insulin therapy, injection site reactions such as pain, itching, hives, swelling and inflammation.
2021-02-01 01:10:36 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:10:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may result in symptoms known as acute pain neuropathy and is usually reversible.
2021-02-01 01:10:37 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:10:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP The first symptoms of hyperglycaemia, such as thirst, increased urine thirst, nausea, vomiting, drowsiness, dry mouth, thirst UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Acetone smelling respiratory UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP symptoms may occur over hours or days. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:10:39 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:10:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Mildly hypoglycaemic patients may be treated by the oral injection of glucose or sugary food. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP subcutaneous or intramuscular injection of glucagon (0.5 to 1.0 mg) by a nurse, or by glucose administered intravenously by the doctor. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Hypoglycaemia may UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:10:40 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:10:44 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was observed in patients with type 1 diabetes (one trial involving 182 patients) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP concentrations of HbA1c were relatively stable during 6-month treatment with Actrapide UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP 2-Diabetes UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP 2-diabetes UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP and UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP and UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP and UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP and UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP and UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:10:44 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:10:44 | INFO | valid | epoch 002 | valid on 'valid' subset | loss 4.282 | nll_loss 2.664 | ppl 6.34 | bleu 32.86 | wps 311.3 | wpb 361 | bsz 12.6 | num_updates 2664 | best_loss 3.813
2021-02-01 01:10:44 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:10:55 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 2 @ 2664 updates, score 4.282) (writing took 10.795375193469226 seconds)
2021-02-01 01:10:55 | INFO | fairseq_cli.train | end of epoch 2 (average epoch stats below)
2021-02-01 01:10:55 | INFO | train | epoch 002 | loss 2.162 | nll_loss 0.313 | ppl 1.24 | wps 7864.2 | ups 8.44 | wpb 932.3 | bsz 70.5 | num_updates 2664 | lr 0.00011655 | gnorm 1.001 | loss_scale 8 | train_wall 131 | wall 345
2021-02-01 01:10:55 | INFO | fairseq_cli.train | begin training epoch 2
2021-02-01 01:10:58 | INFO | train_inner | epoch 003:     36 / 1334 loss=2.155, nll_loss=0.304, ppl=1.23, wps=2729.5, ups=2.92, wpb=936.2, bsz=69.8, num_updates=2700, lr=0.000118125, gnorm=1.129, loss_scale=8, train_wall=10, wall=348
2021-02-01 01:11:08 | INFO | train_inner | epoch 003:    136 / 1334 loss=2.122, nll_loss=0.267, ppl=1.2, wps=9345.2, ups=10.05, wpb=929.7, bsz=70.3, num_updates=2800, lr=0.0001225, gnorm=1.046, loss_scale=8, train_wall=10, wall=358
2021-02-01 01:11:18 | INFO | train_inner | epoch 003:    236 / 1334 loss=2.116, nll_loss=0.263, ppl=1.2, wps=9381.6, ups=10.04, wpb=934.6, bsz=72.7, num_updates=2900, lr=0.000126875, gnorm=0.84, loss_scale=8, train_wall=10, wall=368
2021-02-01 01:11:28 | INFO | train_inner | epoch 003:    336 / 1334 loss=2.14, nll_loss=0.289, ppl=1.22, wps=9304.5, ups=10.01, wpb=929.9, bsz=71, num_updates=3000, lr=0.00013125, gnorm=0.954, loss_scale=8, train_wall=10, wall=378
2021-02-01 01:11:38 | INFO | train_inner | epoch 003:    436 / 1334 loss=2.138, nll_loss=0.285, ppl=1.22, wps=9436.1, ups=10.03, wpb=941, bsz=70.7, num_updates=3100, lr=0.000135625, gnorm=0.807, loss_scale=8, train_wall=10, wall=388
2021-02-01 01:11:48 | INFO | train_inner | epoch 003:    536 / 1334 loss=2.121, nll_loss=0.267, ppl=1.2, wps=9332, ups=10.02, wpb=931.2, bsz=69.7, num_updates=3200, lr=0.00014, gnorm=0.996, loss_scale=8, train_wall=10, wall=398
2021-02-01 01:11:58 | INFO | train_inner | epoch 003:    636 / 1334 loss=2.146, nll_loss=0.295, ppl=1.23, wps=9388.2, ups=10.05, wpb=933.8, bsz=70.3, num_updates=3300, lr=0.000144375, gnorm=1.104, loss_scale=8, train_wall=10, wall=408
2021-02-01 01:12:08 | INFO | train_inner | epoch 003:    736 / 1334 loss=2.133, nll_loss=0.279, ppl=1.21, wps=9296.3, ups=10.01, wpb=928.7, bsz=66.6, num_updates=3400, lr=0.00014875, gnorm=1.301, loss_scale=8, train_wall=10, wall=418
2021-02-01 01:12:18 | INFO | train_inner | epoch 003:    836 / 1334 loss=2.115, nll_loss=0.262, ppl=1.2, wps=9316.8, ups=10.01, wpb=930.3, bsz=71.8, num_updates=3500, lr=0.000153125, gnorm=0.905, loss_scale=8, train_wall=10, wall=428
2021-02-01 01:12:28 | INFO | train_inner | epoch 003:    936 / 1334 loss=2.123, nll_loss=0.271, ppl=1.21, wps=9281.2, ups=10.02, wpb=926.7, bsz=72.1, num_updates=3600, lr=0.0001575, gnorm=0.83, loss_scale=8, train_wall=10, wall=438
2021-02-01 01:12:38 | INFO | train_inner | epoch 003:   1036 / 1334 loss=2.126, nll_loss=0.275, ppl=1.21, wps=9409.3, ups=10.06, wpb=934.9, bsz=72.9, num_updates=3700, lr=0.000161875, gnorm=1.069, loss_scale=8, train_wall=10, wall=448
2021-02-01 01:12:48 | INFO | train_inner | epoch 003:   1136 / 1334 loss=2.134, nll_loss=0.282, ppl=1.22, wps=9330.7, ups=10.02, wpb=931.6, bsz=69.6, num_updates=3800, lr=0.00016625, gnorm=1.013, loss_scale=8, train_wall=10, wall=458
2021-02-01 01:12:58 | INFO | train_inner | epoch 003:   1236 / 1334 loss=2.15, nll_loss=0.297, ppl=1.23, wps=9333.6, ups=10.02, wpb=931.6, bsz=67.8, num_updates=3900, lr=0.000170625, gnorm=1.148, loss_scale=8, train_wall=10, wall=468
2021-02-01 01:13:08 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:13:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP vials 5 x (1 x 10 ml) 1 UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:13:08 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:13:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP These cases should be considered UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:13:09 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:13:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial.
2021-02-01 01:13:09 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:13:10 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP The physician must therefore consider possible interactions and always ask his patients UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:13:10 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:13:10 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall results in rapid absorption compared to other injection sites.
2021-02-01 01:13:10 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:13:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP If the patient cannot be excluded intravenously UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:13:11 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:13:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Subcutaneous or intravenous administration. Actrapide may also be administered intravenously, only be UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:13:11 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:13:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP As with any insulin therapy, injection site reactions such as pain, itching, hives UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:13:12 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:13:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Fast glycaemia control may be associated with UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:13:12 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:13:13 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP The first symptoms of hyperglycaemia such as thirst, nausea, vomiting, drowsiness, dry skin, dry mouth UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:13:13 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:13:14 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Mildly hypoglycaemia may be treated by an intramuscular or subcutaneous injection of glucON (0.5 to 1.0 mg) or glucose UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:13:14 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:13:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide in patients with type 1 diabetes (a study of 182 patients) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:13:14 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:13:14 | INFO | valid | epoch 003 | valid on 'valid' subset | loss 4.999 | nll_loss 3.472 | ppl 11.1 | bleu 21.8 | wps 660.4 | wpb 361 | bsz 12.6 | num_updates 3998 | best_loss 3.813
2021-02-01 01:13:14 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:13:25 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 3 @ 3998 updates, score 4.999) (writing took 10.35927477478981 seconds)
2021-02-01 01:13:25 | INFO | fairseq_cli.train | end of epoch 3 (average epoch stats below)
2021-02-01 01:13:25 | INFO | train | epoch 003 | loss 2.129 | nll_loss 0.276 | ppl 1.21 | wps 8286.4 | ups 8.89 | wpb 932.3 | bsz 70.5 | num_updates 3998 | lr 0.000174913 | gnorm 1 | loss_scale 8 | train_wall 131 | wall 495
2021-02-01 01:13:25 | INFO | fairseq_cli.train | begin training epoch 3
2021-02-01 01:13:25 | INFO | train_inner | epoch 004:      2 / 1334 loss=2.121, nll_loss=0.267, ppl=1.2, wps=3470.3, ups=3.71, wpb=934.5, bsz=71, num_updates=4000, lr=0.000175, gnorm=1.008, loss_scale=8, train_wall=10, wall=495
2021-02-01 01:13:35 | INFO | train_inner | epoch 004:    102 / 1334 loss=2.103, nll_loss=0.245, ppl=1.18, wps=9394.4, ups=10, wpb=939.2, bsz=67.6, num_updates=4100, lr=0.000172853, gnorm=0.889, loss_scale=8, train_wall=10, wall=505
2021-02-01 01:13:45 | INFO | train_inner | epoch 004:    202 / 1334 loss=2.107, nll_loss=0.252, ppl=1.19, wps=9214, ups=9.96, wpb=925.5, bsz=69.5, num_updates=4200, lr=0.000170783, gnorm=0.938, loss_scale=8, train_wall=10, wall=515
2021-02-01 01:13:55 | INFO | train_inner | epoch 004:    302 / 1334 loss=2.13, nll_loss=0.277, ppl=1.21, wps=9253.1, ups=10.04, wpb=921.6, bsz=69.4, num_updates=4300, lr=0.000168785, gnorm=1.166, loss_scale=8, train_wall=10, wall=525
2021-02-01 01:14:05 | INFO | train_inner | epoch 004:    402 / 1334 loss=2.119, nll_loss=0.266, ppl=1.2, wps=9298.5, ups=10.06, wpb=924.3, bsz=68.6, num_updates=4400, lr=0.000166856, gnorm=0.854, loss_scale=8, train_wall=10, wall=535
2021-02-01 01:14:15 | INFO | train_inner | epoch 004:    502 / 1334 loss=2.128, nll_loss=0.275, ppl=1.21, wps=9354.6, ups=10.04, wpb=931.6, bsz=70.3, num_updates=4500, lr=0.000164992, gnorm=0.908, loss_scale=8, train_wall=10, wall=545
2021-02-01 01:14:25 | INFO | train_inner | epoch 004:    602 / 1334 loss=2.109, nll_loss=0.255, ppl=1.19, wps=9266.4, ups=9.97, wpb=929.9, bsz=69.8, num_updates=4600, lr=0.000163188, gnorm=1.043, loss_scale=8, train_wall=10, wall=555
2021-02-01 01:14:35 | INFO | train_inner | epoch 004:    702 / 1334 loss=2.099, nll_loss=0.245, ppl=1.18, wps=9284.3, ups=9.88, wpb=939.8, bsz=71.1, num_updates=4700, lr=0.000161443, gnorm=0.897, loss_scale=8, train_wall=10, wall=565
2021-02-01 01:14:45 | INFO | train_inner | epoch 004:    802 / 1334 loss=2.107, nll_loss=0.255, ppl=1.19, wps=9400.9, ups=9.97, wpb=942.6, bsz=71.2, num_updates=4800, lr=0.000159752, gnorm=0.855, loss_scale=8, train_wall=10, wall=575
2021-02-01 01:14:55 | INFO | train_inner | epoch 004:    902 / 1334 loss=2.115, nll_loss=0.263, ppl=1.2, wps=9331.1, ups=10.04, wpb=929.2, bsz=71.8, num_updates=4900, lr=0.000158114, gnorm=0.81, loss_scale=8, train_wall=10, wall=585
2021-02-01 01:15:05 | INFO | train_inner | epoch 004:   1002 / 1334 loss=2.1, nll_loss=0.245, ppl=1.19, wps=9374.9, ups=9.96, wpb=941.1, bsz=71.2, num_updates=5000, lr=0.000156525, gnorm=0.762, loss_scale=8, train_wall=10, wall=595
2021-02-01 01:15:15 | INFO | train_inner | epoch 004:   1102 / 1334 loss=2.112, nll_loss=0.26, ppl=1.2, wps=9298.7, ups=10.02, wpb=927.6, bsz=71.8, num_updates=5100, lr=0.000154983, gnorm=0.949, loss_scale=8, train_wall=10, wall=605
2021-02-01 01:15:25 | INFO | train_inner | epoch 004:   1202 / 1334 loss=2.11, nll_loss=0.258, ppl=1.2, wps=9340.5, ups=10.02, wpb=932.2, bsz=70.6, num_updates=5200, lr=0.000153485, gnorm=0.826, loss_scale=8, train_wall=10, wall=615
2021-02-01 01:15:35 | INFO | train_inner | epoch 004:   1302 / 1334 loss=2.1, nll_loss=0.247, ppl=1.19, wps=9321.9, ups=9.97, wpb=935.3, bsz=72.5, num_updates=5300, lr=0.00015203, gnorm=0.889, loss_scale=8, train_wall=10, wall=625
2021-02-01 01:15:38 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:15:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP vials 5 x 10 ml) 1 ml UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:39 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:15:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PRODUCT should be considered in these circumstances. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:39 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:15:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial.
2021-02-01 01:15:40 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:15:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PRODUCT must therefore always ask patients about other medicinal products they take. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:40 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:15:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall compared UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:41 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:15:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PRODUCT intravenous treatment should not be UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:41 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:15:42 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Intravenous or intravenous use may also UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:42 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:15:42 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PRODUCTS such as pain, itching and inflammation. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:42 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:15:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PRODUCTS Uncommon - Peripheral neuropathy may be a rapid improvement in blood UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:43 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:15:44 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PRODUCTS such as thirst for urine, nausea, dry skin or days UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:44 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:15:44 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP intraglycaemia may therefore be treated with glucose or 1.5mg). Diabetic should therefore intraglycaemic UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:44 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:15:45 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP (two studies with human insulin (HbA1c). In the studies, Actrapylated blood sugar has UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:15:45 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:15:45 | INFO | valid | epoch 004 | valid on 'valid' subset | loss 5.799 | nll_loss 4.377 | ppl 20.78 | bleu 17.82 | wps 632.5 | wpb 361 | bsz 12.6 | num_updates 5332 | best_loss 3.813
2021-02-01 01:15:45 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:15:53 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 4 @ 5332 updates, score 5.799) (writing took 7.599711391143501 seconds)
2021-02-01 01:15:53 | INFO | fairseq_cli.train | end of epoch 4 (average epoch stats below)
2021-02-01 01:15:53 | INFO | train | epoch 004 | loss 2.11 | nll_loss 0.256 | ppl 1.19 | wps 8403.1 | ups 9.01 | wpb 932.3 | bsz 70.5 | num_updates 5332 | lr 0.000151573 | gnorm 0.898 | loss_scale 8 | train_wall 131 | wall 643
2021-02-01 01:15:53 | INFO | fairseq_cli.train | begin training epoch 4
2021-02-01 01:16:00 | INFO | train_inner | epoch 005:     68 / 1334 loss=2.085, nll_loss=0.23, ppl=1.17, wps=3804.7, ups=4.08, wpb=932.2, bsz=71.4, num_updates=5400, lr=0.000150616, gnorm=0.726, loss_scale=8, train_wall=10, wall=649
2021-02-01 01:16:10 | INFO | train_inner | epoch 005:    168 / 1334 loss=2.088, nll_loss=0.232, ppl=1.17, wps=9344.8, ups=9.99, wpb=935.5, bsz=71.8, num_updates=5500, lr=0.000149241, gnorm=0.924, loss_scale=8, train_wall=10, wall=660
2021-02-01 01:16:20 | INFO | train_inner | epoch 005:    268 / 1334 loss=2.093, nll_loss=0.237, ppl=1.18, wps=9226.8, ups=9.97, wpb=925.9, bsz=68.9, num_updates=5600, lr=0.000147902, gnorm=0.759, loss_scale=8, train_wall=10, wall=670
2021-02-01 01:16:30 | INFO | train_inner | epoch 005:    368 / 1334 loss=2.092, nll_loss=0.236, ppl=1.18, wps=9254.4, ups=10.01, wpb=924.1, bsz=67.9, num_updates=5700, lr=0.000146599, gnorm=0.792, loss_scale=8, train_wall=10, wall=680
2021-02-01 01:16:40 | INFO | train_inner | epoch 005:    468 / 1334 loss=2.087, nll_loss=0.233, ppl=1.18, wps=9387.1, ups=9.97, wpb=941.8, bsz=72, num_updates=5800, lr=0.00014533, gnorm=0.826, loss_scale=8, train_wall=10, wall=690
2021-02-01 01:16:50 | INFO | train_inner | epoch 005:    568 / 1334 loss=2.098, nll_loss=0.244, ppl=1.18, wps=9258.6, ups=10.01, wpb=924.9, bsz=68.6, num_updates=5900, lr=0.000144093, gnorm=1.035, loss_scale=8, train_wall=10, wall=700
2021-02-01 01:17:00 | INFO | train_inner | epoch 005:    668 / 1334 loss=2.093, nll_loss=0.239, ppl=1.18, wps=9425.7, ups=10, wpb=942.6, bsz=71.4, num_updates=6000, lr=0.000142887, gnorm=0.861, loss_scale=8, train_wall=10, wall=710
2021-02-01 01:17:10 | INFO | train_inner | epoch 005:    768 / 1334 loss=2.079, nll_loss=0.225, ppl=1.17, wps=9376.6, ups=9.99, wpb=939, bsz=72.7, num_updates=6100, lr=0.000141711, gnorm=0.581, loss_scale=8, train_wall=10, wall=720
2021-02-01 01:17:20 | INFO | train_inner | epoch 005:    868 / 1334 loss=2.09, nll_loss=0.236, ppl=1.18, wps=9301.7, ups=10.01, wpb=929.6, bsz=69.9, num_updates=6200, lr=0.000140563, gnorm=0.731, loss_scale=8, train_wall=10, wall=730
2021-02-01 01:17:30 | INFO | train_inner | epoch 005:    968 / 1334 loss=2.078, nll_loss=0.224, ppl=1.17, wps=9315.3, ups=10.03, wpb=929.2, bsz=72.3, num_updates=6300, lr=0.000139443, gnorm=0.726, loss_scale=8, train_wall=10, wall=740
2021-02-01 01:17:40 | INFO | train_inner | epoch 005:   1068 / 1334 loss=2.091, nll_loss=0.237, ppl=1.18, wps=9423.1, ups=10.01, wpb=941.8, bsz=69.6, num_updates=6400, lr=0.00013835, gnorm=0.805, loss_scale=8, train_wall=10, wall=750
2021-02-01 01:17:50 | INFO | train_inner | epoch 005:   1168 / 1334 loss=2.09, nll_loss=0.236, ppl=1.18, wps=9321.5, ups=10.04, wpb=928.4, bsz=70.2, num_updates=6500, lr=0.000137281, gnorm=0.679, loss_scale=8, train_wall=10, wall=759
2021-02-01 01:18:00 | INFO | train_inner | epoch 005:   1268 / 1334 loss=2.097, nll_loss=0.244, ppl=1.18, wps=9314.4, ups=10, wpb=931.5, bsz=69.4, num_updates=6600, lr=0.000136237, gnorm=1.228, loss_scale=8, train_wall=10, wall=769
2021-02-01 01:18:06 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:18:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 x 10 ml) 1 ml UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:07 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:18:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP considered when driving a UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:07 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:18:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:08 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:18:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP The physician must therefore take possible interactions UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:08 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:18:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:09 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:18:10 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP glucose solution should be administered intravenously to the patient UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:10 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:18:10 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous or intravenous administration. Actrapide may also be administered intravenously UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:10 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:18:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP As with any insulin therapy, swelling and inflammation may occur. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:11 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:18:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:11 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:18:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Hyperglycaemia, such as thirst for UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:12 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:18:13 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PROglycaemia may be treated with oral UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:13 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:18:13 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in patients with type 1). In the studies, Actrapide failed UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:13 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:18:13 | INFO | valid | epoch 005 | valid on 'valid' subset | loss 5.955 | nll_loss 4.493 | ppl 22.52 | bleu 20.51 | wps 605.3 | wpb 361 | bsz 12.6 | num_updates 6666 | best_loss 3.813
2021-02-01 01:18:13 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:18:23 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 5 @ 6666 updates, score 5.955) (writing took 9.611201140098274 seconds)
2021-02-01 01:18:23 | INFO | fairseq_cli.train | end of epoch 5 (average epoch stats below)
2021-02-01 01:18:23 | INFO | train | epoch 005 | loss 2.09 | nll_loss 0.236 | ppl 1.18 | wps 8278.6 | ups 8.88 | wpb 932.3 | bsz 70.5 | num_updates 6666 | lr 0.000135561 | gnorm 0.824 | loss_scale 8 | train_wall 131 | wall 793
2021-02-01 01:18:23 | INFO | fairseq_cli.train | begin training epoch 5
2021-02-01 01:18:26 | INFO | train_inner | epoch 006:     34 / 1334 loss=2.094, nll_loss=0.242, ppl=1.18, wps=3447.3, ups=3.72, wpb=926.1, bsz=72.1, num_updates=6700, lr=0.000135217, gnorm=0.676, loss_scale=8, train_wall=10, wall=796
2021-02-01 01:18:36 | INFO | train_inner | epoch 006:    134 / 1334 loss=2.072, nll_loss=0.216, ppl=1.16, wps=9347.8, ups=9.98, wpb=936.8, bsz=69.5, num_updates=6800, lr=0.000134219, gnorm=0.582, loss_scale=8, train_wall=10, wall=806
2021-02-01 01:18:46 | INFO | train_inner | epoch 006:    234 / 1334 loss=2.072, nll_loss=0.217, ppl=1.16, wps=9412.3, ups=9.97, wpb=944.4, bsz=70.6, num_updates=6900, lr=0.000133243, gnorm=0.685, loss_scale=8, train_wall=10, wall=816
2021-02-01 01:18:56 | INFO | train_inner | epoch 006:    334 / 1334 loss=2.093, nll_loss=0.239, ppl=1.18, wps=9280.1, ups=9.99, wpb=928.9, bsz=68.3, num_updates=7000, lr=0.000132288, gnorm=0.846, loss_scale=8, train_wall=10, wall=826
2021-02-01 01:19:06 | INFO | train_inner | epoch 006:    434 / 1334 loss=2.078, nll_loss=0.224, ppl=1.17, wps=9270.5, ups=10, wpb=926.8, bsz=71.4, num_updates=7100, lr=0.000131353, gnorm=0.645, loss_scale=8, train_wall=10, wall=836
2021-02-01 01:19:16 | INFO | train_inner | epoch 006:    534 / 1334 loss=2.075, nll_loss=0.221, ppl=1.17, wps=9295.9, ups=10, wpb=929.7, bsz=70.6, num_updates=7200, lr=0.000130437, gnorm=0.663, loss_scale=8, train_wall=10, wall=846
2021-02-01 01:19:26 | INFO | train_inner | epoch 006:    634 / 1334 loss=2.081, nll_loss=0.228, ppl=1.17, wps=9327.3, ups=10.07, wpb=926.6, bsz=70.3, num_updates=7300, lr=0.000129541, gnorm=0.681, loss_scale=8, train_wall=10, wall=856
2021-02-01 01:19:29 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 4.0
2021-02-01 01:19:36 | INFO | train_inner | epoch 006:    735 / 1334 loss=2.074, nll_loss=0.22, ppl=1.16, wps=9218, ups=9.92, wpb=929.5, bsz=70.6, num_updates=7400, lr=0.000128663, gnorm=0.686, loss_scale=5, train_wall=10, wall=866
2021-02-01 01:19:46 | INFO | train_inner | epoch 006:    835 / 1334 loss=2.073, nll_loss=0.218, ppl=1.16, wps=9342.5, ups=9.99, wpb=934.9, bsz=70.3, num_updates=7500, lr=0.000127802, gnorm=0.606, loss_scale=4, train_wall=10, wall=876
2021-02-01 01:19:56 | INFO | train_inner | epoch 006:    935 / 1334 loss=2.082, nll_loss=0.229, ppl=1.17, wps=9384.8, ups=9.99, wpb=939.1, bsz=70.1, num_updates=7600, lr=0.000126958, gnorm=0.628, loss_scale=4, train_wall=10, wall=886
2021-02-01 01:20:06 | INFO | train_inner | epoch 006:   1035 / 1334 loss=2.081, nll_loss=0.228, ppl=1.17, wps=9416.8, ups=10.03, wpb=939.1, bsz=72.3, num_updates=7700, lr=0.000126131, gnorm=0.671, loss_scale=4, train_wall=10, wall=896
2021-02-01 01:20:17 | INFO | train_inner | epoch 006:   1135 / 1334 loss=2.07, nll_loss=0.215, ppl=1.16, wps=9259, ups=9.97, wpb=929, bsz=69, num_updates=7800, lr=0.00012532, gnorm=0.597, loss_scale=4, train_wall=10, wall=906
2021-02-01 01:20:26 | INFO | train_inner | epoch 006:   1235 / 1334 loss=2.072, nll_loss=0.217, ppl=1.16, wps=9285.4, ups=10.01, wpb=927.4, bsz=71.1, num_updates=7900, lr=0.000124524, gnorm=0.55, loss_scale=4, train_wall=10, wall=916
2021-02-01 01:20:36 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:20:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 x 10 ml) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:37 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:20:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP considered when driving. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:37 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:20:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:38 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:20:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP The physician must always ask his patients UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:38 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:20:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP compared with other injections. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:39 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:20:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient must not receive intravenous solution within 10 to 15 minutes. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:40 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:20:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous or intravenous administration. Actrapide can also be applied only intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:40 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:20:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP as with any insulin therapy, swelling and inflammation. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:41 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:20:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP anxiety Uncommon - Peripheral neuropathy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:41 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:20:42 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, such as thirst. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:42 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:20:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glucose (0.5 to 1.0 mg). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:43 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:20:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP (two studies with insulin (HbA1c) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:20:43 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:20:43 | INFO | valid | epoch 006 | valid on 'valid' subset | loss 6.992 | nll_loss 5.692 | ppl 51.71 | bleu 15.03 | wps 668.1 | wpb 361 | bsz 12.6 | num_updates 7999 | best_loss 3.813
2021-02-01 01:20:43 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:20:49 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 6 @ 7999 updates, score 6.992) (writing took 6.311337825842202 seconds)
2021-02-01 01:20:49 | INFO | fairseq_cli.train | end of epoch 6 (average epoch stats below)
2021-02-01 01:20:49 | INFO | train | epoch 006 | loss 2.077 | nll_loss 0.222 | ppl 1.17 | wps 8491.9 | ups 9.11 | wpb 932.3 | bsz 70.5 | num_updates 7999 | lr 0.000123751 | gnorm 0.642 | loss_scale 6 | train_wall 131 | wall 939
2021-02-01 01:20:49 | INFO | fairseq_cli.train | begin training epoch 6
2021-02-01 01:20:49 | INFO | train_inner | epoch 007:      1 / 1334 loss=2.076, nll_loss=0.222, ppl=1.17, wps=4040.1, ups=4.36, wpb=926, bsz=70.1, num_updates=8000, lr=0.000123744, gnorm=0.554, loss_scale=4, train_wall=10, wall=939
2021-02-01 01:20:59 | INFO | train_inner | epoch 007:    101 / 1334 loss=2.068, nll_loss=0.213, ppl=1.16, wps=9393.7, ups=9.99, wpb=940.6, bsz=71.9, num_updates=8100, lr=0.000122977, gnorm=0.613, loss_scale=4, train_wall=10, wall=949
2021-02-01 01:21:09 | INFO | train_inner | epoch 007:    201 / 1334 loss=2.075, nll_loss=0.221, ppl=1.17, wps=9309.9, ups=9.97, wpb=934.2, bsz=72.9, num_updates=8200, lr=0.000122225, gnorm=0.534, loss_scale=4, train_wall=10, wall=959
2021-02-01 01:21:19 | INFO | train_inner | epoch 007:    301 / 1334 loss=2.068, nll_loss=0.212, ppl=1.16, wps=9443.6, ups=10.01, wpb=943.8, bsz=70, num_updates=8300, lr=0.000121487, gnorm=0.556, loss_scale=4, train_wall=10, wall=969
2021-02-01 01:21:29 | INFO | train_inner | epoch 007:    401 / 1334 loss=2.07, nll_loss=0.216, ppl=1.16, wps=9467.6, ups=10.01, wpb=945.6, bsz=70.6, num_updates=8400, lr=0.000120761, gnorm=0.638, loss_scale=4, train_wall=10, wall=979
2021-02-01 01:21:39 | INFO | train_inner | epoch 007:    501 / 1334 loss=2.069, nll_loss=0.216, ppl=1.16, wps=9340.1, ups=9.96, wpb=937.6, bsz=71.8, num_updates=8500, lr=0.000120049, gnorm=0.583, loss_scale=4, train_wall=10, wall=989
2021-02-01 01:21:49 | INFO | train_inner | epoch 007:    601 / 1334 loss=2.069, nll_loss=0.214, ppl=1.16, wps=9134.6, ups=10.06, wpb=908.3, bsz=69.3, num_updates=8600, lr=0.000119349, gnorm=0.626, loss_scale=4, train_wall=10, wall=999
2021-02-01 01:21:59 | INFO | train_inner | epoch 007:    701 / 1334 loss=2.078, nll_loss=0.225, ppl=1.17, wps=9284.6, ups=10.02, wpb=926.2, bsz=70.6, num_updates=8700, lr=0.000118661, gnorm=0.578, loss_scale=4, train_wall=10, wall=1009
2021-02-01 01:22:09 | INFO | train_inner | epoch 007:    801 / 1334 loss=2.071, nll_loss=0.216, ppl=1.16, wps=9254.4, ups=10, wpb=925.4, bsz=68.3, num_updates=8800, lr=0.000117985, gnorm=0.601, loss_scale=4, train_wall=10, wall=1019
2021-02-01 01:22:19 | INFO | train_inner | epoch 007:    901 / 1334 loss=2.069, nll_loss=0.214, ppl=1.16, wps=9082.4, ups=9.97, wpb=911.2, bsz=67.8, num_updates=8900, lr=0.00011732, gnorm=0.724, loss_scale=4, train_wall=10, wall=1029
2021-02-01 01:22:29 | INFO | train_inner | epoch 007:   1001 / 1334 loss=2.062, nll_loss=0.207, ppl=1.15, wps=9299.5, ups=10.01, wpb=928.6, bsz=69.7, num_updates=9000, lr=0.000116667, gnorm=0.657, loss_scale=4, train_wall=10, wall=1039
2021-02-01 01:22:39 | INFO | train_inner | epoch 007:   1101 / 1334 loss=2.071, nll_loss=0.216, ppl=1.16, wps=9306.1, ups=10.02, wpb=928.4, bsz=70.5, num_updates=9100, lr=0.000116024, gnorm=0.621, loss_scale=4, train_wall=10, wall=1049
2021-02-01 01:22:49 | INFO | train_inner | epoch 007:   1201 / 1334 loss=2.065, nll_loss=0.211, ppl=1.16, wps=9530.9, ups=10.02, wpb=951, bsz=70.4, num_updates=9200, lr=0.000115392, gnorm=0.629, loss_scale=4, train_wall=10, wall=1059
2021-02-01 01:22:59 | INFO | train_inner | epoch 007:   1301 / 1334 loss=2.058, nll_loss=0.203, ppl=1.15, wps=9402.2, ups=10.01, wpb=939, bsz=70.9, num_updates=9300, lr=0.00011477, gnorm=0.612, loss_scale=4, train_wall=10, wall=1069
2021-02-01 01:23:03 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:23:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 x 10 ml) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:03 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:23:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP consideration should be considered in these cases UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:04 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:23:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:04 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:23:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP physicians must therefore check that UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:05 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:23:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP compared to other injection sites. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:05 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:23:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient does not receive glucose-galactose solution UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:06 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:23:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous or intravenous administration. Actrapide can also be applied UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:06 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:23:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP itching, and inflammation. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:07 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:23:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP - Peripheral neuropathy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:07 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:23:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia such as thirst UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:08 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:23:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP (0.5 to intravenous glucose.) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:08 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:23:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP (A1-C) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:08 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:23:08 | INFO | valid | epoch 007 | valid on 'valid' subset | loss 8.015 | nll_loss 6.845 | ppl 114.99 | bleu 10.56 | wps 781.8 | wpb 361 | bsz 12.6 | num_updates 9333 | best_loss 3.813
2021-02-01 01:23:08 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:23:15 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 7 @ 9333 updates, score 8.015) (writing took 7.042953943833709 seconds)
2021-02-01 01:23:15 | INFO | fairseq_cli.train | end of epoch 7 (average epoch stats below)
2021-02-01 01:23:15 | INFO | train | epoch 007 | loss 2.069 | nll_loss 0.215 | ppl 1.16 | wps 8513.6 | ups 9.13 | wpb 932.3 | bsz 70.5 | num_updates 9333 | lr 0.000114566 | gnorm 0.61 | loss_scale 4 | train_wall 131 | wall 1085
2021-02-01 01:23:15 | INFO | fairseq_cli.train | begin training epoch 7
2021-02-01 01:23:22 | INFO | train_inner | epoch 008:     67 / 1334 loss=2.065, nll_loss=0.212, ppl=1.16, wps=4128.8, ups=4.4, wpb=938.8, bsz=72, num_updates=9400, lr=0.000114157, gnorm=0.474, loss_scale=4, train_wall=10, wall=1092
2021-02-01 01:23:32 | INFO | train_inner | epoch 008:    167 / 1334 loss=2.073, nll_loss=0.22, ppl=1.16, wps=9373.7, ups=10, wpb=937.1, bsz=73.1, num_updates=9500, lr=0.000113555, gnorm=0.603, loss_scale=4, train_wall=10, wall=1102
2021-02-01 01:23:42 | INFO | train_inner | epoch 008:    267 / 1334 loss=2.065, nll_loss=0.21, ppl=1.16, wps=9344, ups=10.01, wpb=933.8, bsz=70.6, num_updates=9600, lr=0.000112962, gnorm=0.494, loss_scale=4, train_wall=10, wall=1112
2021-02-01 01:23:52 | INFO | train_inner | epoch 008:    367 / 1334 loss=2.066, nll_loss=0.212, ppl=1.16, wps=9422.6, ups=10.06, wpb=936.3, bsz=69.1, num_updates=9700, lr=0.000112378, gnorm=0.529, loss_scale=4, train_wall=10, wall=1122
2021-02-01 01:24:02 | INFO | train_inner | epoch 008:    467 / 1334 loss=2.061, nll_loss=0.206, ppl=1.15, wps=9317.4, ups=10.03, wpb=929, bsz=69.1, num_updates=9800, lr=0.000111803, gnorm=0.481, loss_scale=4, train_wall=10, wall=1132
2021-02-01 01:24:12 | INFO | train_inner | epoch 008:    567 / 1334 loss=2.067, nll_loss=0.214, ppl=1.16, wps=9310.6, ups=10, wpb=931.3, bsz=69.3, num_updates=9900, lr=0.000111237, gnorm=0.603, loss_scale=4, train_wall=10, wall=1142
2021-02-01 01:24:22 | INFO | train_inner | epoch 008:    667 / 1334 loss=2.059, nll_loss=0.204, ppl=1.15, wps=9342.8, ups=10.01, wpb=933.8, bsz=70.4, num_updates=10000, lr=0.00011068, gnorm=0.499, loss_scale=4, train_wall=10, wall=1152
2021-02-01 01:24:32 | INFO | train_inner | epoch 008:    767 / 1334 loss=2.065, nll_loss=0.211, ppl=1.16, wps=9287.9, ups=9.97, wpb=932, bsz=71.5, num_updates=10100, lr=0.00011013, gnorm=0.527, loss_scale=4, train_wall=10, wall=1162
2021-02-01 01:24:42 | INFO | train_inner | epoch 008:    867 / 1334 loss=2.062, nll_loss=0.208, ppl=1.15, wps=9110, ups=10.02, wpb=909.4, bsz=69.6, num_updates=10200, lr=0.000109589, gnorm=0.527, loss_scale=4, train_wall=10, wall=1172
2021-02-01 01:24:52 | INFO | train_inner | epoch 008:    967 / 1334 loss=2.073, nll_loss=0.22, ppl=1.16, wps=9366.6, ups=9.99, wpb=937.4, bsz=71.1, num_updates=10300, lr=0.000109056, gnorm=0.616, loss_scale=4, train_wall=10, wall=1182
2021-02-01 01:25:02 | INFO | train_inner | epoch 008:   1067 / 1334 loss=2.068, nll_loss=0.214, ppl=1.16, wps=9412.2, ups=10, wpb=941.1, bsz=70.8, num_updates=10400, lr=0.00010853, gnorm=0.546, loss_scale=4, train_wall=10, wall=1192
2021-02-01 01:25:13 | INFO | train_inner | epoch 008:   1167 / 1334 loss=2.056, nll_loss=0.201, ppl=1.15, wps=8173.3, ups=8.79, wpb=929.4, bsz=72, num_updates=10500, lr=0.000108012, gnorm=0.504, loss_scale=4, train_wall=11, wall=1203
2021-02-01 01:25:23 | INFO | train_inner | epoch 008:   1267 / 1334 loss=2.06, nll_loss=0.205, ppl=1.15, wps=9176.9, ups=9.97, wpb=920.2, bsz=67.1, num_updates=10600, lr=0.000107502, gnorm=0.678, loss_scale=4, train_wall=10, wall=1213
2021-02-01 01:25:30 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:25:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x 10 ml) 1 ml UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:32 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:25:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:32 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:25:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:33 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:25:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP physicians must therefore ask his patients about medicines they take. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:33 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:25:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP abdominal wall. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:34 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:25:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient must not be intravenous. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:35 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:25:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP intravenous use. Actrapide can also be administered intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:35 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:25:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP insulin reactions may occur at the injection site. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:36 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:25:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy can result in rapid improvement. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:36 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:25:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, dry mouth. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:37 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:25:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glucose is intravenous. or is intravenous. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:38 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:25:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in patients with type 1 insulin it produces (reported in Atrapy1c). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:38 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:25:38 | INFO | valid | epoch 008 | valid on 'valid' subset | loss 7.413 | nll_loss 6.184 | ppl 72.72 | bleu 13.93 | wps 649.6 | wpb 361 | bsz 12.6 | num_updates 10667 | best_loss 3.813
2021-02-01 01:25:38 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:25:45 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 8 @ 10667 updates, score 7.413) (writing took 7.196159154176712 seconds)
2021-02-01 01:25:45 | INFO | fairseq_cli.train | end of epoch 8 (average epoch stats below)
2021-02-01 01:25:45 | INFO | train | epoch 008 | loss 2.064 | nll_loss 0.21 | ppl 1.16 | wps 8290.1 | ups 8.89 | wpb 932.3 | bsz 70.5 | num_updates 10667 | lr 0.000107164 | gnorm 0.546 | loss_scale 4 | train_wall 132 | wall 1235
2021-02-01 01:25:45 | INFO | fairseq_cli.train | begin training epoch 8
2021-02-01 01:25:49 | INFO | train_inner | epoch 009:     33 / 1334 loss=2.062, nll_loss=0.208, ppl=1.15, wps=3704.3, ups=3.95, wpb=938.1, bsz=71.2, num_updates=10700, lr=0.000106998, gnorm=0.535, loss_scale=4, train_wall=10, wall=1239
2021-02-01 01:25:59 | INFO | train_inner | epoch 009:    133 / 1334 loss=2.06, nll_loss=0.205, ppl=1.15, wps=9270.3, ups=10.04, wpb=923, bsz=70.5, num_updates=10800, lr=0.000106502, gnorm=0.449, loss_scale=4, train_wall=10, wall=1249
2021-02-01 01:26:09 | INFO | train_inner | epoch 009:    233 / 1334 loss=2.058, nll_loss=0.203, ppl=1.15, wps=9270.6, ups=10.01, wpb=925.9, bsz=68.6, num_updates=10900, lr=0.000106012, gnorm=0.524, loss_scale=4, train_wall=10, wall=1259
2021-02-01 01:26:19 | INFO | train_inner | epoch 009:    333 / 1334 loss=2.066, nll_loss=0.213, ppl=1.16, wps=9285.7, ups=10, wpb=928.6, bsz=71.8, num_updates=11000, lr=0.000105529, gnorm=0.517, loss_scale=4, train_wall=10, wall=1269
2021-02-01 01:26:29 | INFO | train_inner | epoch 009:    433 / 1334 loss=2.054, nll_loss=0.198, ppl=1.15, wps=9327.3, ups=9.99, wpb=933.7, bsz=69.4, num_updates=11100, lr=0.000105053, gnorm=0.521, loss_scale=4, train_wall=10, wall=1279
2021-02-01 01:26:39 | INFO | train_inner | epoch 009:    533 / 1334 loss=2.048, nll_loss=0.193, ppl=1.14, wps=9387.3, ups=9.98, wpb=940.2, bsz=72.5, num_updates=11200, lr=0.000104583, gnorm=0.355, loss_scale=4, train_wall=10, wall=1289
2021-02-01 01:26:49 | INFO | train_inner | epoch 009:    633 / 1334 loss=2.051, nll_loss=0.197, ppl=1.15, wps=9434.7, ups=10.02, wpb=941.2, bsz=71.8, num_updates=11300, lr=0.000104119, gnorm=0.394, loss_scale=4, train_wall=10, wall=1299
2021-02-01 01:26:59 | INFO | train_inner | epoch 009:    733 / 1334 loss=2.061, nll_loss=0.207, ppl=1.15, wps=9315.2, ups=9.93, wpb=937.6, bsz=70.6, num_updates=11400, lr=0.000103661, gnorm=0.525, loss_scale=4, train_wall=10, wall=1309
2021-02-01 01:27:09 | INFO | train_inner | epoch 009:    833 / 1334 loss=2.062, nll_loss=0.207, ppl=1.15, wps=9321.3, ups=10.03, wpb=929.3, bsz=68.5, num_updates=11500, lr=0.000103209, gnorm=0.578, loss_scale=4, train_wall=10, wall=1319
2021-02-01 01:27:19 | INFO | train_inner | epoch 009:    933 / 1334 loss=2.061, nll_loss=0.207, ppl=1.15, wps=9280.2, ups=9.97, wpb=930.8, bsz=69.7, num_updates=11600, lr=0.000102764, gnorm=0.51, loss_scale=4, train_wall=10, wall=1329
2021-02-01 01:27:29 | INFO | train_inner | epoch 009:   1033 / 1334 loss=2.066, nll_loss=0.213, ppl=1.16, wps=9319.1, ups=9.97, wpb=935, bsz=70, num_updates=11700, lr=0.000102323, gnorm=0.614, loss_scale=4, train_wall=10, wall=1339
2021-02-01 01:27:39 | INFO | train_inner | epoch 009:   1133 / 1334 loss=2.058, nll_loss=0.205, ppl=1.15, wps=9329.5, ups=10.02, wpb=930.9, bsz=71, num_updates=11800, lr=0.000101889, gnorm=0.575, loss_scale=4, train_wall=10, wall=1349
2021-02-01 01:27:49 | INFO | train_inner | epoch 009:   1233 / 1334 loss=2.076, nll_loss=0.224, ppl=1.17, wps=9267.2, ups=10.02, wpb=924.5, bsz=71.3, num_updates=11900, lr=0.00010146, gnorm=0.591, loss_scale=4, train_wall=10, wall=1359
2021-02-01 01:27:59 | INFO | train_inner | epoch 009:   1333 / 1334 loss=2.052, nll_loss=0.198, ppl=1.15, wps=9402.7, ups=9.99, wpb=941.2, bsz=71.2, num_updates=12000, lr=0.000101036, gnorm=0.458, loss_scale=4, train_wall=10, wall=1369
2021-02-01 01:27:59 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:27:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 x 10 ml) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:27:59 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:28:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:00 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:28:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:00 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:28:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the physician must therefore UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:01 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:28:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:02 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:28:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient must not administer intravenously to 15 minutes UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:02 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:28:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Subcutaneous or intravenous use. Actrapide can also be administered intravenously UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:03 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:28:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP such as hives and swelling. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:03 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:28:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy can be UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:04 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:28:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP symptoms such as thirst, nausea, drowsy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:05 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:28:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glycaemia may be treated with oral or UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:05 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:28:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in patients with type 1 insulin (antrapylated human). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:06 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:28:06 | INFO | valid | epoch 009 | valid on 'valid' subset | loss 7.751 | nll_loss 6.536 | ppl 92.8 | bleu 15.59 | wps 657.1 | wpb 361 | bsz 12.6 | num_updates 12001 | best_loss 3.813
2021-02-01 01:28:06 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:28:17 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 9 @ 12001 updates, score 7.751) (writing took 11.398562342859805 seconds)
2021-02-01 01:28:17 | INFO | fairseq_cli.train | end of epoch 9 (average epoch stats below)
2021-02-01 01:28:17 | INFO | train | epoch 009 | loss 2.06 | nll_loss 0.206 | ppl 1.15 | wps 8203.3 | ups 8.8 | wpb 932.3 | bsz 70.5 | num_updates 12001 | lr 0.000101032 | gnorm 0.509 | loss_scale 4 | train_wall 131 | wall 1387
2021-02-01 01:28:17 | INFO | fairseq_cli.train | begin training epoch 9
2021-02-01 01:28:27 | INFO | train_inner | epoch 010:     99 / 1334 loss=2.047, nll_loss=0.192, ppl=1.14, wps=3327.5, ups=3.54, wpb=938.7, bsz=71.8, num_updates=12100, lr=0.000100618, gnorm=0.384, loss_scale=4, train_wall=10, wall=1397
2021-02-01 01:28:37 | INFO | train_inner | epoch 010:    199 / 1334 loss=2.063, nll_loss=0.21, ppl=1.16, wps=9354.4, ups=9.98, wpb=937.6, bsz=71.1, num_updates=12200, lr=0.000100205, gnorm=0.466, loss_scale=4, train_wall=10, wall=1407
2021-02-01 01:28:47 | INFO | train_inner | epoch 010:    299 / 1334 loss=2.064, nll_loss=0.212, ppl=1.16, wps=9327, ups=10, wpb=932.3, bsz=71.1, num_updates=12300, lr=9.97965e-05, gnorm=0.463, loss_scale=4, train_wall=10, wall=1417
2021-02-01 01:28:57 | INFO | train_inner | epoch 010:    399 / 1334 loss=2.05, nll_loss=0.195, ppl=1.14, wps=9383.2, ups=10.01, wpb=937, bsz=70.4, num_updates=12400, lr=9.93933e-05, gnorm=0.557, loss_scale=4, train_wall=10, wall=1427
2021-02-01 01:29:07 | INFO | train_inner | epoch 010:    499 / 1334 loss=2.057, nll_loss=0.203, ppl=1.15, wps=9296.4, ups=9.97, wpb=932.8, bsz=69.8, num_updates=12500, lr=9.89949e-05, gnorm=0.452, loss_scale=4, train_wall=10, wall=1437
2021-02-01 01:29:17 | INFO | train_inner | epoch 010:    599 / 1334 loss=2.058, nll_loss=0.203, ppl=1.15, wps=9224.2, ups=10, wpb=922.4, bsz=68.4, num_updates=12600, lr=9.86013e-05, gnorm=0.499, loss_scale=4, train_wall=10, wall=1447
2021-02-01 01:29:27 | INFO | train_inner | epoch 010:    699 / 1334 loss=2.058, nll_loss=0.205, ppl=1.15, wps=9294.5, ups=10.02, wpb=927.8, bsz=72.1, num_updates=12700, lr=9.82124e-05, gnorm=0.38, loss_scale=4, train_wall=10, wall=1457
2021-02-01 01:29:37 | INFO | train_inner | epoch 010:    799 / 1334 loss=2.052, nll_loss=0.198, ppl=1.15, wps=9344.2, ups=9.98, wpb=936.2, bsz=70.3, num_updates=12800, lr=9.7828e-05, gnorm=0.398, loss_scale=4, train_wall=10, wall=1467
2021-02-01 01:29:47 | INFO | train_inner | epoch 010:    899 / 1334 loss=2.059, nll_loss=0.205, ppl=1.15, wps=9397.4, ups=10.02, wpb=938.1, bsz=69.4, num_updates=12900, lr=9.74481e-05, gnorm=0.489, loss_scale=4, train_wall=10, wall=1477
2021-02-01 01:29:57 | INFO | train_inner | epoch 010:    999 / 1334 loss=2.044, nll_loss=0.19, ppl=1.14, wps=9331.6, ups=10.01, wpb=932.5, bsz=71.3, num_updates=13000, lr=9.70725e-05, gnorm=0.415, loss_scale=4, train_wall=10, wall=1487
2021-02-01 01:30:07 | INFO | train_inner | epoch 010:   1099 / 1334 loss=2.062, nll_loss=0.21, ppl=1.16, wps=9117.3, ups=9.95, wpb=916.1, bsz=71, num_updates=13100, lr=9.67013e-05, gnorm=0.499, loss_scale=4, train_wall=10, wall=1497
2021-02-01 01:30:17 | INFO | train_inner | epoch 010:   1199 / 1334 loss=2.058, nll_loss=0.204, ppl=1.15, wps=9331.4, ups=10, wpb=933.5, bsz=70.1, num_updates=13200, lr=9.63343e-05, gnorm=0.471, loss_scale=4, train_wall=10, wall=1507
2021-02-01 01:30:27 | INFO | train_inner | epoch 010:   1299 / 1334 loss=2.063, nll_loss=0.21, ppl=1.16, wps=9367.8, ups=9.96, wpb=940.2, bsz=71.4, num_updates=13300, lr=9.59715e-05, gnorm=0.453, loss_scale=4, train_wall=10, wall=1517
2021-02-01 01:30:31 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:30:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 ml) 1 ml UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:31 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:30:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP considered during these cases. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:32 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:30:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:32 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:30:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP take possible interactions. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:33 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:30:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection sites. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:33 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:30:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient must not intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:34 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:30:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous use. Actrapide may also be administered intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:34 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:30:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP as with any insulin therapy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:35 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:30:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy rapidly improvement in glycaemic control may UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:35 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:30:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP symptoms of hyperglycaemia, such as thirst. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:36 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:30:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP or intravenous glucose. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:36 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:30:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP type 1 diabetes (antrapylated A1c). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:30:37 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:30:37 | INFO | valid | epoch 010 | valid on 'valid' subset | loss 8.098 | nll_loss 6.953 | ppl 123.91 | bleu 13.26 | wps 680.8 | wpb 361 | bsz 12.6 | num_updates 13335 | best_loss 3.813
2021-02-01 01:30:37 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:30:44 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 10 @ 13335 updates, score 8.098) (writing took 6.7213067365810275 seconds)
2021-02-01 01:30:44 | INFO | fairseq_cli.train | end of epoch 10 (average epoch stats below)
2021-02-01 01:30:44 | INFO | train | epoch 010 | loss 2.057 | nll_loss 0.203 | ppl 1.15 | wps 8472.4 | ups 9.09 | wpb 932.3 | bsz 70.5 | num_updates 13335 | lr 9.58455e-05 | gnorm 0.459 | loss_scale 4 | train_wall 131 | wall 1534
2021-02-01 01:30:44 | INFO | fairseq_cli.train | begin training epoch 10
2021-02-01 01:30:50 | INFO | train_inner | epoch 011:     65 / 1334 loss=2.057, nll_loss=0.204, ppl=1.15, wps=4029.3, ups=4.3, wpb=936.1, bsz=69.4, num_updates=13400, lr=9.56127e-05, gnorm=0.451, loss_scale=4, train_wall=10, wall=1540
2021-02-01 01:31:00 | INFO | train_inner | epoch 011:    165 / 1334 loss=2.06, nll_loss=0.207, ppl=1.15, wps=9136.8, ups=9.86, wpb=926.6, bsz=70.6, num_updates=13500, lr=9.52579e-05, gnorm=0.424, loss_scale=4, train_wall=10, wall=1550
2021-02-01 01:31:11 | INFO | train_inner | epoch 011:    265 / 1334 loss=2.049, nll_loss=0.194, ppl=1.14, wps=9228.2, ups=9.89, wpb=932.9, bsz=70.7, num_updates=13600, lr=9.49071e-05, gnorm=0.334, loss_scale=4, train_wall=10, wall=1561
2021-02-01 01:31:21 | INFO | train_inner | epoch 011:    365 / 1334 loss=2.052, nll_loss=0.198, ppl=1.15, wps=9264.5, ups=9.93, wpb=932.7, bsz=70.4, num_updates=13700, lr=9.45601e-05, gnorm=0.399, loss_scale=4, train_wall=10, wall=1571
2021-02-01 01:31:31 | INFO | train_inner | epoch 011:    465 / 1334 loss=2.061, nll_loss=0.208, ppl=1.15, wps=9215.2, ups=9.92, wpb=928.8, bsz=70.1, num_updates=13800, lr=9.42168e-05, gnorm=0.402, loss_scale=4, train_wall=10, wall=1581
2021-02-01 01:31:41 | INFO | train_inner | epoch 011:    565 / 1334 loss=2.054, nll_loss=0.2, ppl=1.15, wps=9158.5, ups=9.84, wpb=930.6, bsz=69.4, num_updates=13900, lr=9.38773e-05, gnorm=0.407, loss_scale=4, train_wall=10, wall=1591
2021-02-01 01:31:51 | INFO | train_inner | epoch 011:    665 / 1334 loss=2.058, nll_loss=0.205, ppl=1.15, wps=9334.5, ups=9.95, wpb=938.4, bsz=71.2, num_updates=14000, lr=9.35414e-05, gnorm=0.556, loss_scale=4, train_wall=10, wall=1601
2021-02-01 01:32:01 | INFO | train_inner | epoch 011:    765 / 1334 loss=2.048, nll_loss=0.194, ppl=1.14, wps=9239.4, ups=9.96, wpb=927.5, bsz=72.8, num_updates=14100, lr=9.32091e-05, gnorm=0.457, loss_scale=4, train_wall=10, wall=1611
2021-02-01 01:32:11 | INFO | train_inner | epoch 011:    865 / 1334 loss=2.057, nll_loss=0.203, ppl=1.15, wps=9240.3, ups=9.96, wpb=927.8, bsz=69.8, num_updates=14200, lr=9.28804e-05, gnorm=0.563, loss_scale=4, train_wall=10, wall=1621
2021-02-01 01:32:21 | INFO | train_inner | epoch 011:    965 / 1334 loss=2.053, nll_loss=0.199, ppl=1.15, wps=9326.2, ups=9.9, wpb=941.7, bsz=70, num_updates=14300, lr=9.2555e-05, gnorm=0.535, loss_scale=4, train_wall=10, wall=1631
2021-02-01 01:32:31 | INFO | train_inner | epoch 011:   1065 / 1334 loss=2.055, nll_loss=0.201, ppl=1.15, wps=9159.2, ups=9.89, wpb=926.2, bsz=69.6, num_updates=14400, lr=9.22331e-05, gnorm=0.799, loss_scale=4, train_wall=10, wall=1641
2021-02-01 01:32:41 | INFO | train_inner | epoch 011:   1165 / 1334 loss=2.056, nll_loss=0.204, ppl=1.15, wps=9244.6, ups=9.9, wpb=934.2, bsz=71.3, num_updates=14500, lr=9.19145e-05, gnorm=0.437, loss_scale=4, train_wall=10, wall=1651
2021-02-01 01:32:51 | INFO | train_inner | epoch 011:   1265 / 1334 loss=2.053, nll_loss=0.199, ppl=1.15, wps=9330.5, ups=9.93, wpb=939.9, bsz=69.6, num_updates=14600, lr=9.15992e-05, gnorm=0.415, loss_scale=4, train_wall=10, wall=1661
2021-02-01 01:32:58 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:32:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x 10 ml) 1 ml UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:32:59 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:32:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP these cases should be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:32:59 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:33:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:00 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:33:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP take possible interactions UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:00 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:33:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:01 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:33:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient must not produce a glucose solution intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:02 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:33:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Subcutaneous or intravenous use. Actrapide may also be administered intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:02 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:33:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP as with any insulin therapy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:03 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:33:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy rapid improvement in blood glycaemic UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:03 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:33:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, such as thirst. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:04 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:33:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glycaemia may be treated with an intraglycose (0.5 mg) should UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:05 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:33:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in patients at 2-1) Actrapylated insulin (antrapylated human trial of 6-month) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:33:05 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:33:05 | INFO | valid | epoch 011 | valid on 'valid' subset | loss 8.289 | nll_loss 7.161 | ppl 143.16 | bleu 14.07 | wps 650 | wpb 361 | bsz 12.6 | num_updates 14669 | best_loss 3.813
2021-02-01 01:33:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:33:13 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 11 @ 14669 updates, score 8.289) (writing took 8.224276002496481 seconds)
2021-02-01 01:33:13 | INFO | fairseq_cli.train | end of epoch 11 (average epoch stats below)
2021-02-01 01:33:13 | INFO | train | epoch 011 | loss 2.054 | nll_loss 0.201 | ppl 1.15 | wps 8314 | ups 8.92 | wpb 932.3 | bsz 70.5 | num_updates 14669 | lr 9.13835e-05 | gnorm 0.469 | loss_scale 4 | train_wall 132 | wall 1683
2021-02-01 01:33:13 | INFO | fairseq_cli.train | begin training epoch 11
2021-02-01 01:33:17 | INFO | train_inner | epoch 012:     31 / 1334 loss=2.044, nll_loss=0.188, ppl=1.14, wps=3703.8, ups=3.98, wpb=930.5, bsz=69.4, num_updates=14700, lr=9.12871e-05, gnorm=0.378, loss_scale=4, train_wall=10, wall=1687
2021-02-01 01:33:27 | INFO | train_inner | epoch 012:    131 / 1334 loss=2.053, nll_loss=0.199, ppl=1.15, wps=9251.1, ups=9.9, wpb=934.5, bsz=71, num_updates=14800, lr=9.09782e-05, gnorm=0.386, loss_scale=4, train_wall=10, wall=1697
2021-02-01 01:33:37 | INFO | train_inner | epoch 012:    231 / 1334 loss=2.055, nll_loss=0.202, ppl=1.15, wps=9245, ups=9.96, wpb=928.4, bsz=71.9, num_updates=14900, lr=9.06724e-05, gnorm=0.432, loss_scale=4, train_wall=10, wall=1707
2021-02-01 01:33:47 | INFO | train_inner | epoch 012:    331 / 1334 loss=2.048, nll_loss=0.194, ppl=1.14, wps=9267.1, ups=9.94, wpb=932, bsz=70.6, num_updates=15000, lr=9.03696e-05, gnorm=0.332, loss_scale=4, train_wall=10, wall=1717
2021-02-01 01:33:57 | INFO | train_inner | epoch 012:    431 / 1334 loss=2.044, nll_loss=0.189, ppl=1.14, wps=9157.8, ups=9.93, wpb=922.1, bsz=69.1, num_updates=15100, lr=9.00699e-05, gnorm=0.407, loss_scale=4, train_wall=10, wall=1727
2021-02-01 01:34:07 | INFO | train_inner | epoch 012:    531 / 1334 loss=2.052, nll_loss=0.2, ppl=1.15, wps=9239.9, ups=9.89, wpb=934.2, bsz=71.6, num_updates=15200, lr=8.97731e-05, gnorm=0.425, loss_scale=4, train_wall=10, wall=1737
2021-02-01 01:34:17 | INFO | train_inner | epoch 012:    631 / 1334 loss=2.049, nll_loss=0.195, ppl=1.14, wps=9296, ups=9.86, wpb=943.2, bsz=70.3, num_updates=15300, lr=8.94792e-05, gnorm=0.416, loss_scale=4, train_wall=10, wall=1747
2021-02-01 01:34:27 | INFO | train_inner | epoch 012:    731 / 1334 loss=2.067, nll_loss=0.216, ppl=1.16, wps=9220.9, ups=9.94, wpb=927.8, bsz=69.8, num_updates=15400, lr=8.91883e-05, gnorm=0.507, loss_scale=4, train_wall=10, wall=1757
2021-02-01 01:34:37 | INFO | train_inner | epoch 012:    831 / 1334 loss=2.053, nll_loss=0.199, ppl=1.15, wps=9362.1, ups=9.94, wpb=942, bsz=68.4, num_updates=15500, lr=8.89001e-05, gnorm=0.446, loss_scale=4, train_wall=10, wall=1767
2021-02-01 01:34:47 | INFO | train_inner | epoch 012:    931 / 1334 loss=2.058, nll_loss=0.205, ppl=1.15, wps=9312.3, ups=9.91, wpb=939.4, bsz=72.6, num_updates=15600, lr=8.86147e-05, gnorm=0.442, loss_scale=4, train_wall=10, wall=1777
2021-02-01 01:34:57 | INFO | train_inner | epoch 012:   1031 / 1334 loss=2.059, nll_loss=0.206, ppl=1.15, wps=9163.4, ups=9.91, wpb=925.1, bsz=70.9, num_updates=15700, lr=8.8332e-05, gnorm=0.434, loss_scale=4, train_wall=10, wall=1787
2021-02-01 01:35:07 | INFO | train_inner | epoch 012:   1131 / 1334 loss=2.047, nll_loss=0.193, ppl=1.14, wps=9238.9, ups=9.91, wpb=932.5, bsz=69.4, num_updates=15800, lr=8.80521e-05, gnorm=0.361, loss_scale=4, train_wall=10, wall=1797
2021-02-01 01:35:18 | INFO | train_inner | epoch 012:   1231 / 1334 loss=2.051, nll_loss=0.197, ppl=1.15, wps=9229.6, ups=9.92, wpb=930.1, bsz=70.1, num_updates=15900, lr=8.77747e-05, gnorm=0.411, loss_scale=4, train_wall=10, wall=1808
2021-02-01 01:35:28 | INFO | train_inner | epoch 012:   1331 / 1334 loss=2.055, nll_loss=0.201, ppl=1.15, wps=9238.1, ups=10, wpb=923.4, bsz=69.3, num_updates=16000, lr=8.75e-05, gnorm=0.402, loss_scale=4, train_wall=10, wall=1818
2021-02-01 01:35:28 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:35:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x 1 ml) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:28 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:35:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP consideration should be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:29 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:35:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:29 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:35:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP physician must therefore ask his patients UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:30 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:35:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall versus other injection sites. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:30 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:35:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient within 10 to 15 minutes UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:31 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:35:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous or intravenous use. Actrapide can also be applied intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:32 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:35:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP as with any insulin therapy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:32 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:35:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Nervous disorders can be associated with acute pain. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:33 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:35:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, such as thirst UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:34 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:35:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glucose or subcutaneous food. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:34 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:35:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in patients with Atrapylether in the pancreas UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:35:35 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:35:35 | INFO | valid | epoch 012 | valid on 'valid' subset | loss 8.326 | nll_loss 7.209 | ppl 147.94 | bleu 13.17 | wps 644.1 | wpb 361 | bsz 12.6 | num_updates 16003 | best_loss 3.813
2021-02-01 01:35:35 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:35:41 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 12 @ 16003 updates, score 8.326) (writing took 6.713923130184412 seconds)
2021-02-01 01:35:41 | INFO | fairseq_cli.train | end of epoch 12 (average epoch stats below)
2021-02-01 01:35:41 | INFO | train | epoch 012 | loss 2.053 | nll_loss 0.199 | ppl 1.15 | wps 8403.1 | ups 9.01 | wpb 932.3 | bsz 70.5 | num_updates 16003 | lr 8.74918e-05 | gnorm 0.414 | loss_scale 4 | train_wall 132 | wall 1831
2021-02-01 01:35:41 | INFO | fairseq_cli.train | begin training epoch 12
2021-02-01 01:35:51 | INFO | train_inner | epoch 013:     97 / 1334 loss=2.041, nll_loss=0.186, ppl=1.14, wps=3996.8, ups=4.23, wpb=945, bsz=68.8, num_updates=16100, lr=8.72278e-05, gnorm=0.391, loss_scale=4, train_wall=10, wall=1841
2021-02-01 01:36:01 | INFO | train_inner | epoch 013:    197 / 1334 loss=2.04, nll_loss=0.185, ppl=1.14, wps=9135.7, ups=9.91, wpb=921.4, bsz=71.3, num_updates=16200, lr=8.69582e-05, gnorm=0.311, loss_scale=4, train_wall=10, wall=1851
2021-02-01 01:36:11 | INFO | train_inner | epoch 013:    297 / 1334 loss=2.047, nll_loss=0.193, ppl=1.14, wps=9167.2, ups=9.92, wpb=923.7, bsz=67.8, num_updates=16300, lr=8.6691e-05, gnorm=0.377, loss_scale=4, train_wall=10, wall=1861
2021-02-01 01:36:21 | INFO | train_inner | epoch 013:    397 / 1334 loss=2.05, nll_loss=0.197, ppl=1.15, wps=9274, ups=9.95, wpb=932, bsz=70.3, num_updates=16400, lr=8.64263e-05, gnorm=0.387, loss_scale=4, train_wall=10, wall=1871
2021-02-01 01:36:31 | INFO | train_inner | epoch 013:    497 / 1334 loss=2.049, nll_loss=0.195, ppl=1.14, wps=9358.5, ups=9.97, wpb=938.8, bsz=69.4, num_updates=16500, lr=8.6164e-05, gnorm=0.372, loss_scale=4, train_wall=10, wall=1881
2021-02-01 01:36:41 | INFO | train_inner | epoch 013:    597 / 1334 loss=2.053, nll_loss=0.2, ppl=1.15, wps=9352.6, ups=9.99, wpb=936.6, bsz=70.6, num_updates=16600, lr=8.59041e-05, gnorm=0.401, loss_scale=4, train_wall=10, wall=1891
2021-02-01 01:36:51 | INFO | train_inner | epoch 013:    697 / 1334 loss=2.058, nll_loss=0.206, ppl=1.15, wps=9255, ups=9.97, wpb=928.2, bsz=71.5, num_updates=16700, lr=8.56465e-05, gnorm=0.391, loss_scale=4, train_wall=10, wall=1901
2021-02-01 01:37:02 | INFO | train_inner | epoch 013:    797 / 1334 loss=2.043, nll_loss=0.189, ppl=1.14, wps=9280.4, ups=9.89, wpb=938.4, bsz=71.8, num_updates=16800, lr=8.53913e-05, gnorm=0.301, loss_scale=4, train_wall=10, wall=1912
2021-02-01 01:37:12 | INFO | train_inner | epoch 013:    897 / 1334 loss=2.05, nll_loss=0.196, ppl=1.15, wps=9152.3, ups=9.9, wpb=924.5, bsz=69.3, num_updates=16900, lr=8.51382e-05, gnorm=0.361, loss_scale=4, train_wall=10, wall=1922
2021-02-01 01:37:22 | INFO | train_inner | epoch 013:    997 / 1334 loss=2.05, nll_loss=0.198, ppl=1.15, wps=9247.3, ups=9.91, wpb=932.7, bsz=72, num_updates=17000, lr=8.48875e-05, gnorm=0.353, loss_scale=4, train_wall=10, wall=1932
2021-02-01 01:37:32 | INFO | train_inner | epoch 013:   1097 / 1334 loss=2.054, nll_loss=0.2, ppl=1.15, wps=9178, ups=9.91, wpb=926.4, bsz=69, num_updates=17100, lr=8.46389e-05, gnorm=0.4, loss_scale=4, train_wall=10, wall=1942
2021-02-01 01:37:42 | INFO | train_inner | epoch 013:   1197 / 1334 loss=2.068, nll_loss=0.218, ppl=1.16, wps=9210.1, ups=9.82, wpb=938.2, bsz=73.1, num_updates=17200, lr=8.43925e-05, gnorm=0.514, loss_scale=4, train_wall=10, wall=1952
2021-02-01 01:37:52 | INFO | train_inner | epoch 013:   1297 / 1334 loss=2.066, nll_loss=0.215, ppl=1.16, wps=9202.9, ups=9.92, wpb=927.4, bsz=71.4, num_updates=17300, lr=8.41482e-05, gnorm=0.412, loss_scale=4, train_wall=10, wall=1962
2021-02-01 01:37:56 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:37:56 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 10 ml) 1 vials UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:37:56 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:37:57 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP these cases should be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:37:57 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:37:57 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:37:57 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:37:58 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the physician must therefore ask his patients about they. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:37:58 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:37:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall compared UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:37:59 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:37:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP intravenous route has to UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:37:59 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:38:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP intravenous or intravenous staff. Actrapide may also be administered intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:38:00 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:38:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP insulin reactions may occur in the injection site UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:38:01 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:38:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy, rapid improvement in blood UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:38:01 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:38:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, dry over days UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:38:02 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:38:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glucose control should be intravenous or UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:38:02 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:38:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP (Atrapy-1-Diabetes in H-C) - UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:38:03 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:38:03 | INFO | valid | epoch 013 | valid on 'valid' subset | loss 8.084 | nll_loss 6.962 | ppl 124.71 | bleu 12.52 | wps 630.6 | wpb 361 | bsz 12.6 | num_updates 17337 | best_loss 3.813
2021-02-01 01:38:03 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:38:14 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 13 @ 17337 updates, score 8.084) (writing took 10.930647371336818 seconds)
2021-02-01 01:38:14 | INFO | fairseq_cli.train | end of epoch 13 (average epoch stats below)
2021-02-01 01:38:14 | INFO | train | epoch 013 | loss 2.052 | nll_loss 0.198 | ppl 1.15 | wps 8158.7 | ups 8.75 | wpb 932.3 | bsz 70.5 | num_updates 17337 | lr 8.40584e-05 | gnorm 0.384 | loss_scale 4 | train_wall 132 | wall 1984
2021-02-01 01:38:14 | INFO | fairseq_cli.train | begin training epoch 13
2021-02-01 01:38:20 | INFO | train_inner | epoch 014:     63 / 1334 loss=2.052, nll_loss=0.198, ppl=1.15, wps=3333.3, ups=3.58, wpb=931.9, bsz=69.8, num_updates=17400, lr=8.39061e-05, gnorm=0.508, loss_scale=4, train_wall=10, wall=1990
2021-02-01 01:38:30 | INFO | train_inner | epoch 014:    163 / 1334 loss=2.045, nll_loss=0.191, ppl=1.14, wps=9299.5, ups=9.9, wpb=939.6, bsz=69.5, num_updates=17500, lr=8.3666e-05, gnorm=0.338, loss_scale=4, train_wall=10, wall=2000
2021-02-01 01:38:40 | INFO | train_inner | epoch 014:    263 / 1334 loss=2.045, nll_loss=0.191, ppl=1.14, wps=9158.3, ups=9.92, wpb=923.2, bsz=68.9, num_updates=17600, lr=8.3428e-05, gnorm=0.347, loss_scale=4, train_wall=10, wall=2010
2021-02-01 01:38:50 | INFO | train_inner | epoch 014:    363 / 1334 loss=2.052, nll_loss=0.2, ppl=1.15, wps=9335.8, ups=9.97, wpb=936, bsz=73.8, num_updates=17700, lr=8.3192e-05, gnorm=0.349, loss_scale=4, train_wall=10, wall=2020
2021-02-01 01:39:00 | INFO | train_inner | epoch 014:    463 / 1334 loss=2.047, nll_loss=0.194, ppl=1.14, wps=9233.5, ups=9.95, wpb=927.6, bsz=70.5, num_updates=17800, lr=8.2958e-05, gnorm=0.322, loss_scale=4, train_wall=10, wall=2030
2021-02-01 01:39:10 | INFO | train_inner | epoch 014:    563 / 1334 loss=2.053, nll_loss=0.2, ppl=1.15, wps=9078.9, ups=9.91, wpb=916.5, bsz=67.4, num_updates=17900, lr=8.27259e-05, gnorm=0.489, loss_scale=4, train_wall=10, wall=2040
2021-02-01 01:39:20 | INFO | train_inner | epoch 014:    663 / 1334 loss=2.045, nll_loss=0.191, ppl=1.14, wps=9415.7, ups=10.01, wpb=940.6, bsz=71.6, num_updates=18000, lr=8.24958e-05, gnorm=0.343, loss_scale=4, train_wall=10, wall=2050
2021-02-01 01:39:30 | INFO | train_inner | epoch 014:    763 / 1334 loss=2.057, nll_loss=0.204, ppl=1.15, wps=9256.9, ups=9.97, wpb=928.4, bsz=68.2, num_updates=18100, lr=8.22676e-05, gnorm=0.46, loss_scale=4, train_wall=10, wall=2060
2021-02-01 01:39:40 | INFO | train_inner | epoch 014:    863 / 1334 loss=2.055, nll_loss=0.202, ppl=1.15, wps=9233.4, ups=10.04, wpb=919.8, bsz=69.8, num_updates=18200, lr=8.20413e-05, gnorm=0.436, loss_scale=4, train_wall=10, wall=2070
2021-02-01 01:39:50 | INFO | train_inner | epoch 014:    963 / 1334 loss=2.043, nll_loss=0.189, ppl=1.14, wps=9296.4, ups=9.99, wpb=930.9, bsz=71.8, num_updates=18300, lr=8.18168e-05, gnorm=0.322, loss_scale=4, train_wall=10, wall=2080
2021-02-01 01:40:00 | INFO | train_inner | epoch 014:   1063 / 1334 loss=2.046, nll_loss=0.192, ppl=1.14, wps=9402.3, ups=9.98, wpb=942, bsz=71, num_updates=18400, lr=8.15942e-05, gnorm=0.35, loss_scale=4, train_wall=10, wall=2090
2021-02-01 01:40:11 | INFO | train_inner | epoch 014:   1163 / 1334 loss=2.052, nll_loss=0.199, ppl=1.15, wps=9328.3, ups=9.96, wpb=936.7, bsz=70.6, num_updates=18500, lr=8.13733e-05, gnorm=0.687, loss_scale=4, train_wall=10, wall=2100
2021-02-01 01:40:21 | INFO | train_inner | epoch 014:   1263 / 1334 loss=2.057, nll_loss=0.205, ppl=1.15, wps=9329.2, ups=9.93, wpb=939.8, bsz=71.4, num_updates=18600, lr=8.11543e-05, gnorm=0.387, loss_scale=4, train_wall=10, wall=2111
2021-02-01 01:40:28 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:40:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 ml) 1 vials) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:28 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:40:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP these cases should be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:29 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:40:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:29 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:40:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the physician must therefore ask his patients about other medicinal products. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:30 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:40:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall compared UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:30 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:40:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient must not exceed 10 to 15 minutes. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:31 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:40:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous use. Actrapide can also be administered intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:32 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:40:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP as with any insulin therapy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:32 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:40:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy rapid improvement in blood UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:33 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:40:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, dry mouth. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:33 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:40:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glucose control or glucose. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:34 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:40:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP (2H-1C). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:40:34 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:40:34 | INFO | valid | epoch 014 | valid on 'valid' subset | loss 8.238 | nll_loss 7.133 | ppl 140.39 | bleu 15.29 | wps 686.7 | wpb 361 | bsz 12.6 | num_updates 18671 | best_loss 3.813
2021-02-01 01:40:34 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:40:46 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 14 @ 18671 updates, score 8.238) (writing took 11.747770700603724 seconds)
2021-02-01 01:40:46 | INFO | fairseq_cli.train | end of epoch 14 (average epoch stats below)
2021-02-01 01:40:46 | INFO | train | epoch 014 | loss 2.05 | nll_loss 0.197 | ppl 1.15 | wps 8175.2 | ups 8.77 | wpb 932.3 | bsz 70.5 | num_updates 18671 | lr 8.09999e-05 | gnorm 0.407 | loss_scale 4 | train_wall 132 | wall 2136
2021-02-01 01:40:46 | INFO | fairseq_cli.train | begin training epoch 14
2021-02-01 01:40:49 | INFO | train_inner | epoch 015:     29 / 1334 loss=2.055, nll_loss=0.203, ppl=1.15, wps=3334.3, ups=3.54, wpb=941.8, bsz=72.2, num_updates=18700, lr=8.0937e-05, gnorm=0.368, loss_scale=4, train_wall=10, wall=2139
2021-02-01 01:40:59 | INFO | train_inner | epoch 015:    129 / 1334 loss=2.041, nll_loss=0.186, ppl=1.14, wps=9407.2, ups=10.05, wpb=936.4, bsz=69.4, num_updates=18800, lr=8.07215e-05, gnorm=0.308, loss_scale=4, train_wall=10, wall=2149
2021-02-01 01:41:09 | INFO | train_inner | epoch 015:    229 / 1334 loss=2.046, nll_loss=0.192, ppl=1.14, wps=9182, ups=10.01, wpb=917.6, bsz=68.7, num_updates=18900, lr=8.05076e-05, gnorm=0.358, loss_scale=4, train_wall=10, wall=2159
2021-02-01 01:41:19 | INFO | train_inner | epoch 015:    329 / 1334 loss=2.044, nll_loss=0.191, ppl=1.14, wps=9372.3, ups=9.97, wpb=940.1, bsz=71.8, num_updates=19000, lr=8.02955e-05, gnorm=0.31, loss_scale=4, train_wall=10, wall=2169
2021-02-01 01:41:29 | INFO | train_inner | epoch 015:    429 / 1334 loss=2.053, nll_loss=0.2, ppl=1.15, wps=9342.6, ups=9.97, wpb=937.4, bsz=69.8, num_updates=19100, lr=8.0085e-05, gnorm=0.426, loss_scale=4, train_wall=10, wall=2179
2021-02-01 01:41:39 | INFO | train_inner | epoch 015:    529 / 1334 loss=2.055, nll_loss=0.203, ppl=1.15, wps=9320.9, ups=10.03, wpb=929.2, bsz=70, num_updates=19200, lr=7.98762e-05, gnorm=0.388, loss_scale=4, train_wall=10, wall=2189
2021-02-01 01:41:49 | INFO | train_inner | epoch 015:    629 / 1334 loss=2.046, nll_loss=0.193, ppl=1.14, wps=9405.7, ups=10.01, wpb=939.4, bsz=72.3, num_updates=19300, lr=7.9669e-05, gnorm=0.299, loss_scale=4, train_wall=10, wall=2199
2021-02-01 01:41:59 | INFO | train_inner | epoch 015:    729 / 1334 loss=2.056, nll_loss=0.204, ppl=1.15, wps=9330.8, ups=9.99, wpb=934.3, bsz=71.8, num_updates=19400, lr=7.94634e-05, gnorm=0.388, loss_scale=4, train_wall=10, wall=2209
2021-02-01 01:42:09 | INFO | train_inner | epoch 015:    829 / 1334 loss=2.051, nll_loss=0.198, ppl=1.15, wps=9404.7, ups=10, wpb=940.4, bsz=71.4, num_updates=19500, lr=7.92594e-05, gnorm=0.388, loss_scale=4, train_wall=10, wall=2219
2021-02-01 01:42:19 | INFO | train_inner | epoch 015:    929 / 1334 loss=2.045, nll_loss=0.191, ppl=1.14, wps=9363.1, ups=9.99, wpb=937.6, bsz=70.8, num_updates=19600, lr=7.90569e-05, gnorm=0.31, loss_scale=4, train_wall=10, wall=2229
2021-02-01 01:42:29 | INFO | train_inner | epoch 015:   1029 / 1334 loss=2.041, nll_loss=0.187, ppl=1.14, wps=9201, ups=10.04, wpb=916.7, bsz=69.4, num_updates=19700, lr=7.8856e-05, gnorm=0.322, loss_scale=4, train_wall=10, wall=2239
2021-02-01 01:42:39 | INFO | train_inner | epoch 015:   1129 / 1334 loss=2.061, nll_loss=0.209, ppl=1.16, wps=9283.9, ups=9.96, wpb=932.3, bsz=69.2, num_updates=19800, lr=7.86567e-05, gnorm=0.563, loss_scale=4, train_wall=10, wall=2249
2021-02-01 01:42:49 | INFO | train_inner | epoch 015:   1229 / 1334 loss=2.046, nll_loss=0.192, ppl=1.14, wps=9195.7, ups=9.96, wpb=923.3, bsz=69.2, num_updates=19900, lr=7.84588e-05, gnorm=0.346, loss_scale=4, train_wall=10, wall=2259
2021-02-01 01:42:59 | INFO | train_inner | epoch 015:   1329 / 1334 loss=2.051, nll_loss=0.199, ppl=1.15, wps=9350.5, ups=10, wpb=935, bsz=71.5, num_updates=20000, lr=7.82624e-05, gnorm=0.33, loss_scale=4, train_wall=10, wall=2269
2021-02-01 01:42:59 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:43:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 ml) 1 UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:00 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:43:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP should be considered in these cases. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:00 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:43:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml Actrapide in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:01 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:43:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the physician must therefore UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:01 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:43:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous abdominal wall compared UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:02 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:43:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient should not be administered intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:03 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:43:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Subcutaneous or intravenous administration may also be applied UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:03 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:43:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP as with any insulin site. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:04 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:43:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy rapid improvement in blood control UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:04 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:43:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, dry mouth. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:05 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:43:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glucose supplementation should therefore be treated with UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:05 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:43:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in patients with Actrapylin 1-Diabetes (UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:43:06 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:43:06 | INFO | valid | epoch 015 | valid on 'valid' subset | loss 8.803 | nll_loss 7.737 | ppl 213.37 | bleu 13.4 | wps 699.8 | wpb 361 | bsz 12.6 | num_updates 20005 | best_loss 3.813
2021-02-01 01:43:06 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:43:17 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 15 @ 20005 updates, score 8.803) (writing took 11.584886169061065 seconds)
2021-02-01 01:43:17 | INFO | fairseq_cli.train | end of epoch 15 (average epoch stats below)
2021-02-01 01:43:17 | INFO | train | epoch 015 | loss 2.049 | nll_loss 0.196 | ppl 1.15 | wps 8217.6 | ups 8.81 | wpb 932.3 | bsz 70.5 | num_updates 20005 | lr 7.82526e-05 | gnorm 0.363 | loss_scale 4 | train_wall 131 | wall 2287
2021-02-01 01:43:17 | INFO | fairseq_cli.train | begin training epoch 15
2021-02-01 01:43:27 | INFO | train_inner | epoch 016:     95 / 1334 loss=2.04, nll_loss=0.185, ppl=1.14, wps=3321, ups=3.59, wpb=924.8, bsz=71.1, num_updates=20100, lr=7.80675e-05, gnorm=0.254, loss_scale=4, train_wall=10, wall=2297
2021-02-01 01:43:37 | INFO | train_inner | epoch 016:    195 / 1334 loss=2.052, nll_loss=0.2, ppl=1.15, wps=9333.6, ups=9.97, wpb=936.6, bsz=71.2, num_updates=20200, lr=7.7874e-05, gnorm=0.423, loss_scale=4, train_wall=10, wall=2307
2021-02-01 01:43:47 | INFO | train_inner | epoch 016:    295 / 1334 loss=2.046, nll_loss=0.193, ppl=1.14, wps=9337.7, ups=10.02, wpb=932.2, bsz=72.2, num_updates=20300, lr=7.76819e-05, gnorm=0.334, loss_scale=4, train_wall=10, wall=2317
2021-02-01 01:43:57 | INFO | train_inner | epoch 016:    395 / 1334 loss=2.048, nll_loss=0.195, ppl=1.14, wps=9382.6, ups=10.01, wpb=937.5, bsz=70.3, num_updates=20400, lr=7.74913e-05, gnorm=0.375, loss_scale=4, train_wall=10, wall=2327
2021-02-01 01:44:07 | INFO | train_inner | epoch 016:    495 / 1334 loss=2.052, nll_loss=0.2, ppl=1.15, wps=9431.8, ups=10.02, wpb=941.1, bsz=69.5, num_updates=20500, lr=7.73021e-05, gnorm=0.415, loss_scale=4, train_wall=10, wall=2337
2021-02-01 01:44:17 | INFO | train_inner | epoch 016:    595 / 1334 loss=2.044, nll_loss=0.191, ppl=1.14, wps=9231, ups=9.95, wpb=927.3, bsz=71, num_updates=20600, lr=7.71142e-05, gnorm=0.329, loss_scale=4, train_wall=10, wall=2347
2021-02-01 01:44:27 | INFO | train_inner | epoch 016:    695 / 1334 loss=2.048, nll_loss=0.195, ppl=1.14, wps=9350.8, ups=10.03, wpb=932.3, bsz=69.1, num_updates=20700, lr=7.69277e-05, gnorm=0.379, loss_scale=4, train_wall=10, wall=2357
2021-02-01 01:44:37 | INFO | train_inner | epoch 016:    795 / 1334 loss=2.042, nll_loss=0.188, ppl=1.14, wps=9354.4, ups=10, wpb=935, bsz=71.8, num_updates=20800, lr=7.67426e-05, gnorm=0.292, loss_scale=4, train_wall=10, wall=2367
2021-02-01 01:44:47 | INFO | train_inner | epoch 016:    895 / 1334 loss=2.06, nll_loss=0.208, ppl=1.15, wps=9218.4, ups=10.02, wpb=919.9, bsz=68.9, num_updates=20900, lr=7.65588e-05, gnorm=0.505, loss_scale=4, train_wall=10, wall=2377
2021-02-01 01:44:57 | INFO | train_inner | epoch 016:    995 / 1334 loss=2.046, nll_loss=0.193, ppl=1.14, wps=9303.2, ups=10.02, wpb=928.6, bsz=70, num_updates=21000, lr=7.63763e-05, gnorm=0.468, loss_scale=4, train_wall=10, wall=2387
2021-02-01 01:45:07 | INFO | train_inner | epoch 016:   1095 / 1334 loss=2.051, nll_loss=0.198, ppl=1.15, wps=9281.1, ups=10.03, wpb=925.7, bsz=69.5, num_updates=21100, lr=7.61951e-05, gnorm=0.47, loss_scale=4, train_wall=10, wall=2397
2021-02-01 01:45:17 | INFO | train_inner | epoch 016:   1195 / 1334 loss=2.051, nll_loss=0.199, ppl=1.15, wps=9365.8, ups=9.99, wpb=937.3, bsz=70.2, num_updates=21200, lr=7.60151e-05, gnorm=0.403, loss_scale=4, train_wall=10, wall=2407
2021-02-01 01:45:27 | INFO | train_inner | epoch 016:   1295 / 1334 loss=2.049, nll_loss=0.197, ppl=1.15, wps=9363.4, ups=10.06, wpb=931.2, bsz=70.4, num_updates=21300, lr=7.58365e-05, gnorm=0.339, loss_scale=4, train_wall=10, wall=2417
2021-02-01 01:45:31 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:45:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x 1 ml) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:31 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:45:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP these cases should be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:32 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:45:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:32 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:45:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the physician must therefore ask other medicinal products. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:32 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:45:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous absorption sites. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:33 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:45:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP patient should not be administered glucose-system within 10 to 15 minutes. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:34 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:45:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Subcutaneous use may also be applied intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:34 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:45:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP any injection site, such as pain UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:35 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:45:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy with UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:35 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:45:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP symptoms of thirst, dry mouth. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:36 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:45:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glucose supplementation should be administered subcutaneously with UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:36 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:45:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP (6-month treatment with Atrapylitaxel) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:45:36 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:45:36 | INFO | valid | epoch 016 | valid on 'valid' subset | loss 8.768 | nll_loss 7.693 | ppl 206.94 | bleu 13.17 | wps 741.4 | wpb 361 | bsz 12.6 | num_updates 21339 | best_loss 3.813
2021-02-01 01:45:36 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:45:51 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 16 @ 21339 updates, score 8.768) (writing took 14.162913290783763 seconds)
2021-02-01 01:45:51 | INFO | fairseq_cli.train | end of epoch 16 (average epoch stats below)
2021-02-01 01:45:51 | INFO | train | epoch 016 | loss 2.048 | nll_loss 0.195 | ppl 1.15 | wps 8108 | ups 8.7 | wpb 932.3 | bsz 70.5 | num_updates 21339 | lr 7.57672e-05 | gnorm 0.381 | loss_scale 4 | train_wall 131 | wall 2441
2021-02-01 01:45:51 | INFO | fairseq_cli.train | begin training epoch 16
2021-02-01 01:45:57 | INFO | train_inner | epoch 017:     61 / 1334 loss=2.043, nll_loss=0.19, ppl=1.14, wps=3142, ups=3.32, wpb=946.4, bsz=72.2, num_updates=21400, lr=7.56591e-05, gnorm=0.351, loss_scale=4, train_wall=10, wall=2447
2021-02-01 01:46:07 | INFO | train_inner | epoch 017:    161 / 1334 loss=2.041, nll_loss=0.186, ppl=1.14, wps=9239.8, ups=10.01, wpb=923.3, bsz=68.4, num_updates=21500, lr=7.54829e-05, gnorm=0.363, loss_scale=4, train_wall=10, wall=2457
2021-02-01 01:46:17 | INFO | train_inner | epoch 017:    261 / 1334 loss=2.044, nll_loss=0.19, ppl=1.14, wps=9285.5, ups=9.94, wpb=934.1, bsz=69.2, num_updates=21600, lr=7.5308e-05, gnorm=0.319, loss_scale=4, train_wall=10, wall=2467
2021-02-01 01:46:27 | INFO | train_inner | epoch 017:    361 / 1334 loss=2.05, nll_loss=0.198, ppl=1.15, wps=9417.1, ups=10.02, wpb=940.3, bsz=72.7, num_updates=21700, lr=7.51343e-05, gnorm=0.341, loss_scale=4, train_wall=10, wall=2477
2021-02-01 01:46:37 | INFO | train_inner | epoch 017:    461 / 1334 loss=2.046, nll_loss=0.193, ppl=1.14, wps=9432.4, ups=10.03, wpb=940.3, bsz=70.3, num_updates=21800, lr=7.49618e-05, gnorm=0.347, loss_scale=4, train_wall=10, wall=2487
2021-02-01 01:46:47 | INFO | train_inner | epoch 017:    561 / 1334 loss=2.053, nll_loss=0.201, ppl=1.15, wps=9414.2, ups=9.96, wpb=945, bsz=71.3, num_updates=21900, lr=7.47904e-05, gnorm=0.376, loss_scale=4, train_wall=10, wall=2497
2021-02-01 01:46:57 | INFO | train_inner | epoch 017:    661 / 1334 loss=2.05, nll_loss=0.198, ppl=1.15, wps=9287, ups=10, wpb=928.4, bsz=70.7, num_updates=22000, lr=7.46203e-05, gnorm=0.31, loss_scale=4, train_wall=10, wall=2507
2021-02-01 01:47:07 | INFO | train_inner | epoch 017:    761 / 1334 loss=2.052, nll_loss=0.199, ppl=1.15, wps=9206.3, ups=9.97, wpb=923.6, bsz=69.8, num_updates=22100, lr=7.44512e-05, gnorm=0.398, loss_scale=4, train_wall=10, wall=2517
2021-02-01 01:47:17 | INFO | train_inner | epoch 017:    861 / 1334 loss=2.041, nll_loss=0.188, ppl=1.14, wps=9324.8, ups=10.01, wpb=931.5, bsz=71.2, num_updates=22200, lr=7.42834e-05, gnorm=0.279, loss_scale=4, train_wall=10, wall=2527
2021-02-01 01:47:27 | INFO | train_inner | epoch 017:    961 / 1334 loss=2.049, nll_loss=0.198, ppl=1.15, wps=9357.7, ups=10, wpb=935.8, bsz=71.4, num_updates=22300, lr=7.41166e-05, gnorm=0.39, loss_scale=4, train_wall=10, wall=2537
2021-02-01 01:47:37 | INFO | train_inner | epoch 017:   1061 / 1334 loss=2.046, nll_loss=0.193, ppl=1.14, wps=9293.1, ups=10.02, wpb=927.3, bsz=70.6, num_updates=22400, lr=7.3951e-05, gnorm=0.349, loss_scale=4, train_wall=10, wall=2547
2021-02-01 01:47:47 | INFO | train_inner | epoch 017:   1161 / 1334 loss=2.046, nll_loss=0.193, ppl=1.14, wps=9210.3, ups=9.97, wpb=923.8, bsz=70.1, num_updates=22500, lr=7.37865e-05, gnorm=0.337, loss_scale=4, train_wall=10, wall=2557
2021-02-01 01:47:57 | INFO | train_inner | epoch 017:   1261 / 1334 loss=2.053, nll_loss=0.201, ppl=1.15, wps=9294.4, ups=10.03, wpb=927.1, bsz=69, num_updates=22600, lr=7.36231e-05, gnorm=1.174, loss_scale=4, train_wall=10, wall=2567
2021-02-01 01:48:04 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:48:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 ml) 1 vials) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:05 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:48:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP these cases should be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:05 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:48:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:06 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:48:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP physicians must therefore ask his patients. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:06 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:48:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:07 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:48:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP patient should not be administered glucose intravenously. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:07 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:48:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous administration. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:08 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:48:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP any insulin therapy, itching, UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:08 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:48:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy can be associated. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:09 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:48:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, dry mouth. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:09 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:48:10 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP intravenous route or glucose. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:10 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:48:10 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Actrapy-treated (type 1) was not well UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:48:10 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:48:10 | INFO | valid | epoch 017 | valid on 'valid' subset | loss 9.229 | nll_loss 8.221 | ppl 298.31 | bleu 12.12 | wps 754.2 | wpb 361 | bsz 12.6 | num_updates 22673 | best_loss 3.813
2021-02-01 01:48:10 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:48:21 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 17 @ 22673 updates, score 9.229) (writing took 10.956650293432176 seconds)
2021-02-01 01:48:21 | INFO | fairseq_cli.train | end of epoch 17 (average epoch stats below)
2021-02-01 01:48:21 | INFO | train | epoch 017 | loss 2.047 | nll_loss 0.195 | ppl 1.14 | wps 8273.8 | ups 8.87 | wpb 932.3 | bsz 70.5 | num_updates 22673 | lr 7.35044e-05 | gnorm 0.411 | loss_scale 4 | train_wall 131 | wall 2591
2021-02-01 01:48:21 | INFO | fairseq_cli.train | begin training epoch 17
2021-02-01 01:48:24 | INFO | train_inner | epoch 018:     27 / 1334 loss=2.044, nll_loss=0.191, ppl=1.14, wps=3495.9, ups=3.72, wpb=938.5, bsz=70.3, num_updates=22700, lr=7.34607e-05, gnorm=0.319, loss_scale=4, train_wall=10, wall=2594
2021-02-01 01:48:34 | INFO | train_inner | epoch 018:    127 / 1334 loss=2.041, nll_loss=0.187, ppl=1.14, wps=9232.3, ups=10.02, wpb=921, bsz=67.9, num_updates=22800, lr=7.32994e-05, gnorm=0.311, loss_scale=4, train_wall=10, wall=2604
2021-02-01 01:48:44 | INFO | train_inner | epoch 018:    227 / 1334 loss=2.052, nll_loss=0.2, ppl=1.15, wps=9182.6, ups=9.96, wpb=921.9, bsz=66.9, num_updates=22900, lr=7.31392e-05, gnorm=0.395, loss_scale=4, train_wall=10, wall=2614
2021-02-01 01:48:54 | INFO | train_inner | epoch 018:    327 / 1334 loss=2.051, nll_loss=0.199, ppl=1.15, wps=9191.1, ups=9.99, wpb=919.8, bsz=68.5, num_updates=23000, lr=7.298e-05, gnorm=0.393, loss_scale=4, train_wall=10, wall=2624
2021-02-01 01:49:04 | INFO | train_inner | epoch 018:    427 / 1334 loss=2.045, nll_loss=0.192, ppl=1.14, wps=9244.2, ups=9.88, wpb=936.1, bsz=71, num_updates=23100, lr=7.28219e-05, gnorm=0.37, loss_scale=4, train_wall=10, wall=2634
2021-02-01 01:49:14 | INFO | train_inner | epoch 018:    527 / 1334 loss=2.04, nll_loss=0.186, ppl=1.14, wps=9334.2, ups=9.99, wpb=934.3, bsz=72, num_updates=23200, lr=7.26648e-05, gnorm=0.333, loss_scale=4, train_wall=10, wall=2644
2021-02-01 01:49:24 | INFO | train_inner | epoch 018:    627 / 1334 loss=2.049, nll_loss=0.197, ppl=1.15, wps=9412.9, ups=10.04, wpb=937.1, bsz=71.8, num_updates=23300, lr=7.25087e-05, gnorm=0.357, loss_scale=4, train_wall=10, wall=2654
2021-02-01 01:49:34 | INFO | train_inner | epoch 018:    727 / 1334 loss=2.045, nll_loss=0.192, ppl=1.14, wps=9392, ups=10.03, wpb=936.3, bsz=70, num_updates=23400, lr=7.23536e-05, gnorm=0.308, loss_scale=4, train_wall=10, wall=2664
2021-02-01 01:49:44 | INFO | train_inner | epoch 018:    827 / 1334 loss=2.044, nll_loss=0.191, ppl=1.14, wps=9343.1, ups=10.05, wpb=929.8, bsz=70.3, num_updates=23500, lr=7.21995e-05, gnorm=0.335, loss_scale=4, train_wall=10, wall=2674
2021-02-01 01:49:54 | INFO | train_inner | epoch 018:    927 / 1334 loss=2.053, nll_loss=0.202, ppl=1.15, wps=9344.1, ups=10.05, wpb=929.6, bsz=73, num_updates=23600, lr=7.20464e-05, gnorm=0.334, loss_scale=4, train_wall=10, wall=2684
2021-02-01 01:50:04 | INFO | train_inner | epoch 018:   1027 / 1334 loss=2.042, nll_loss=0.189, ppl=1.14, wps=9367.9, ups=10.01, wpb=935.6, bsz=70.3, num_updates=23700, lr=7.18942e-05, gnorm=0.334, loss_scale=4, train_wall=10, wall=2694
2021-02-01 01:50:14 | INFO | train_inner | epoch 018:   1127 / 1334 loss=2.043, nll_loss=0.19, ppl=1.14, wps=9336.7, ups=9.96, wpb=937.8, bsz=72.1, num_updates=23800, lr=7.1743e-05, gnorm=0.366, loss_scale=8, train_wall=10, wall=2704
2021-02-01 01:50:24 | INFO | train_inner | epoch 018:   1227 / 1334 loss=2.052, nll_loss=0.2, ppl=1.15, wps=9317.6, ups=10.01, wpb=930.9, bsz=69, num_updates=23900, lr=7.15928e-05, gnorm=0.36, loss_scale=8, train_wall=10, wall=2714
2021-02-01 01:50:34 | INFO | train_inner | epoch 018:   1327 / 1334 loss=2.051, nll_loss=0.199, ppl=1.15, wps=9461.9, ups=10.05, wpb=941.9, bsz=72.6, num_updates=24000, lr=7.14435e-05, gnorm=0.367, loss_scale=8, train_wall=10, wall=2724
2021-02-01 01:50:34 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:50:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 ml) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:35 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:50:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP should be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:35 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:50:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:36 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:50:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the physician must therefore ask other medicinal products. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:36 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:50:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection into the abdominal wall. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:37 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:50:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient must not be glucose-galactose. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:37 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:50:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous administration. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:38 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:50:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP such as pain and swelling. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:38 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:50:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Glycaemic control may be associated. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:39 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:50:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP symptoms of thirst, generally increased UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:39 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:50:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP therefore be treated by glucose. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:39 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:50:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in two months with Atrapylin (HbA1c). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:50:40 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:50:40 | INFO | valid | epoch 018 | valid on 'valid' subset | loss 9.192 | nll_loss 8.172 | ppl 288.48 | bleu 10.97 | wps 786.6 | wpb 361 | bsz 12.6 | num_updates 24007 | best_loss 3.813
2021-02-01 01:50:40 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:50:54 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 18 @ 24007 updates, score 9.192) (writing took 13.987694579176605 seconds)
2021-02-01 01:50:54 | INFO | fairseq_cli.train | end of epoch 18 (average epoch stats below)
2021-02-01 01:50:54 | INFO | train | epoch 018 | loss 2.047 | nll_loss 0.194 | ppl 1.14 | wps 8127.5 | ups 8.72 | wpb 932.3 | bsz 70.5 | num_updates 24007 | lr 7.1433e-05 | gnorm 0.35 | loss_scale 5 | train_wall 131 | wall 2744
2021-02-01 01:50:54 | INFO | fairseq_cli.train | begin training epoch 18
2021-02-01 01:51:03 | INFO | train_inner | epoch 019:     93 / 1334 loss=2.06, nll_loss=0.209, ppl=1.16, wps=3060.8, ups=3.37, wpb=909.5, bsz=69.4, num_updates=24100, lr=7.12951e-05, gnorm=0.435, loss_scale=8, train_wall=10, wall=2753
2021-02-01 01:51:14 | INFO | train_inner | epoch 019:    193 / 1334 loss=2.039, nll_loss=0.186, ppl=1.14, wps=9132.1, ups=9.73, wpb=938.5, bsz=72.1, num_updates=24200, lr=7.11476e-05, gnorm=0.268, loss_scale=8, train_wall=10, wall=2764
2021-02-01 01:51:24 | INFO | train_inner | epoch 019:    293 / 1334 loss=2.045, nll_loss=0.192, ppl=1.14, wps=9143.6, ups=9.77, wpb=936.3, bsz=71.9, num_updates=24300, lr=7.10011e-05, gnorm=0.447, loss_scale=8, train_wall=10, wall=2774
2021-02-01 01:51:34 | INFO | train_inner | epoch 019:    393 / 1334 loss=2.048, nll_loss=0.196, ppl=1.15, wps=9027, ups=9.75, wpb=925.9, bsz=69, num_updates=24400, lr=7.08554e-05, gnorm=0.371, loss_scale=8, train_wall=10, wall=2784
2021-02-01 01:51:44 | INFO | train_inner | epoch 019:    493 / 1334 loss=2.046, nll_loss=0.194, ppl=1.14, wps=9140.5, ups=9.82, wpb=931.2, bsz=69.8, num_updates=24500, lr=7.07107e-05, gnorm=0.414, loss_scale=8, train_wall=10, wall=2794
2021-02-01 01:51:55 | INFO | train_inner | epoch 019:    593 / 1334 loss=2.044, nll_loss=0.19, ppl=1.14, wps=9119, ups=9.77, wpb=933.8, bsz=69.4, num_updates=24600, lr=7.05668e-05, gnorm=0.322, loss_scale=8, train_wall=10, wall=2805
2021-02-01 01:52:05 | INFO | train_inner | epoch 019:    693 / 1334 loss=2.038, nll_loss=0.185, ppl=1.14, wps=9219.7, ups=9.84, wpb=937, bsz=70, num_updates=24700, lr=7.04238e-05, gnorm=0.32, loss_scale=8, train_wall=10, wall=2815
2021-02-01 01:52:15 | INFO | train_inner | epoch 019:    793 / 1334 loss=2.042, nll_loss=0.189, ppl=1.14, wps=9226.7, ups=9.8, wpb=941.6, bsz=70, num_updates=24800, lr=7.02817e-05, gnorm=0.445, loss_scale=8, train_wall=10, wall=2825
2021-02-01 01:52:25 | INFO | train_inner | epoch 019:    893 / 1334 loss=2.06, nll_loss=0.21, ppl=1.16, wps=9197.1, ups=9.79, wpb=939.1, bsz=72.9, num_updates=24900, lr=7.01404e-05, gnorm=0.358, loss_scale=8, train_wall=10, wall=2835
2021-02-01 01:52:35 | INFO | train_inner | epoch 019:    993 / 1334 loss=2.049, nll_loss=0.196, ppl=1.15, wps=9050.3, ups=9.76, wpb=927.7, bsz=68.6, num_updates=25000, lr=7e-05, gnorm=0.307, loss_scale=8, train_wall=10, wall=2845
2021-02-01 01:52:46 | INFO | train_inner | epoch 019:   1093 / 1334 loss=2.042, nll_loss=0.189, ppl=1.14, wps=9100.4, ups=9.81, wpb=927.8, bsz=71.1, num_updates=25100, lr=6.98604e-05, gnorm=0.363, loss_scale=8, train_wall=10, wall=2856
2021-02-01 01:52:56 | INFO | train_inner | epoch 019:   1193 / 1334 loss=2.054, nll_loss=0.203, ppl=1.15, wps=9260.1, ups=9.82, wpb=942.7, bsz=71, num_updates=25200, lr=6.97217e-05, gnorm=0.37, loss_scale=8, train_wall=10, wall=2866
2021-02-01 01:53:06 | INFO | train_inner | epoch 019:   1293 / 1334 loss=2.041, nll_loss=0.188, ppl=1.14, wps=9112.2, ups=9.79, wpb=931, bsz=71, num_updates=25300, lr=6.95837e-05, gnorm=0.301, loss_scale=8, train_wall=10, wall=2876
2021-02-01 01:53:10 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:53:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x (1 ml) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:11 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:53:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP should be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:11 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:53:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:12 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:53:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the physician must therefore ask other medicines. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:12 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:53:13 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous absorption sites, compared UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:13 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:53:13 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP the patient should not be glucose solved. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:13 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:53:14 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Subcutaneous use may also be applied. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:14 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:53:14 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP as with any insulin therapy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:14 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:53:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy Fast improvement in blood disorders may UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:15 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:53:16 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, dry mouth, vomiting UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:16 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:53:16 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP glucose fluids or glucose. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:16 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:53:17 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP (Atrapy1-Diabetes) was not well controlled in Atrapylin UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:53:17 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:53:17 | INFO | valid | epoch 019 | valid on 'valid' subset | loss 9.057 | nll_loss 8.022 | ppl 260 | bleu 12.34 | wps 668.9 | wpb 361 | bsz 12.6 | num_updates 25341 | best_loss 3.813
2021-02-01 01:53:17 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:53:37 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 19 @ 25341 updates, score 9.057) (writing took 19.85538574680686 seconds)
2021-02-01 01:53:37 | INFO | fairseq_cli.train | end of epoch 19 (average epoch stats below)
2021-02-01 01:53:37 | INFO | train | epoch 019 | loss 2.046 | nll_loss 0.194 | ppl 1.14 | wps 7646.1 | ups 8.2 | wpb 932.3 | bsz 70.5 | num_updates 25341 | lr 6.95274e-05 | gnorm 0.364 | loss_scale 8 | train_wall 134 | wall 2907
2021-02-01 01:53:37 | INFO | fairseq_cli.train | begin training epoch 19
2021-02-01 01:53:43 | INFO | train_inner | epoch 020:     59 / 1334 loss=2.047, nll_loss=0.194, ppl=1.14, wps=2540.9, ups=2.72, wpb=935.1, bsz=68.9, num_updates=25400, lr=6.94466e-05, gnorm=0.41, loss_scale=8, train_wall=10, wall=2913
2021-02-01 01:53:53 | INFO | train_inner | epoch 020:    159 / 1334 loss=2.043, nll_loss=0.19, ppl=1.14, wps=9212, ups=9.85, wpb=935.5, bsz=70.4, num_updates=25500, lr=6.93103e-05, gnorm=0.355, loss_scale=8, train_wall=10, wall=2923
2021-02-01 01:54:03 | INFO | train_inner | epoch 020:    259 / 1334 loss=2.052, nll_loss=0.2, ppl=1.15, wps=9143.5, ups=9.82, wpb=931.2, bsz=69.6, num_updates=25600, lr=6.91748e-05, gnorm=0.381, loss_scale=8, train_wall=10, wall=2933
2021-02-01 01:54:13 | INFO | train_inner | epoch 020:    359 / 1334 loss=2.039, nll_loss=0.185, ppl=1.14, wps=9178.6, ups=9.87, wpb=929.9, bsz=71, num_updates=25700, lr=6.90401e-05, gnorm=0.299, loss_scale=8, train_wall=10, wall=2943
2021-02-01 01:54:23 | INFO | train_inner | epoch 020:    459 / 1334 loss=2.046, nll_loss=0.194, ppl=1.14, wps=9076.1, ups=9.8, wpb=926.5, bsz=70.3, num_updates=25800, lr=6.89062e-05, gnorm=0.336, loss_scale=8, train_wall=10, wall=2953
2021-02-01 01:54:34 | INFO | train_inner | epoch 020:    559 / 1334 loss=2.049, nll_loss=0.197, ppl=1.15, wps=9150, ups=9.85, wpb=928.9, bsz=68.6, num_updates=25900, lr=6.8773e-05, gnorm=0.363, loss_scale=8, train_wall=10, wall=2964
2021-02-01 01:54:44 | INFO | train_inner | epoch 020:    659 / 1334 loss=2.047, nll_loss=0.194, ppl=1.14, wps=9058.4, ups=9.75, wpb=929.5, bsz=70.5, num_updates=26000, lr=6.86406e-05, gnorm=0.399, loss_scale=8, train_wall=10, wall=2974
2021-02-01 01:54:54 | INFO | train_inner | epoch 020:    759 / 1334 loss=2.043, nll_loss=0.191, ppl=1.14, wps=9144.4, ups=9.81, wpb=932.2, bsz=71.4, num_updates=26100, lr=6.8509e-05, gnorm=0.362, loss_scale=8, train_wall=10, wall=2984
2021-02-01 01:55:04 | INFO | train_inner | epoch 020:    859 / 1334 loss=2.047, nll_loss=0.196, ppl=1.15, wps=9244.9, ups=9.84, wpb=939.2, bsz=72, num_updates=26200, lr=6.83782e-05, gnorm=0.362, loss_scale=8, train_wall=10, wall=2994
2021-02-01 01:55:14 | INFO | train_inner | epoch 020:    959 / 1334 loss=2.049, nll_loss=0.197, ppl=1.15, wps=9206.9, ups=9.82, wpb=937.5, bsz=71.4, num_updates=26300, lr=6.8248e-05, gnorm=0.347, loss_scale=8, train_wall=10, wall=3004
2021-02-01 01:55:25 | INFO | train_inner | epoch 020:   1059 / 1334 loss=2.044, nll_loss=0.192, ppl=1.14, wps=9179.7, ups=9.84, wpb=932.7, bsz=70.5, num_updates=26400, lr=6.81187e-05, gnorm=0.339, loss_scale=8, train_wall=10, wall=3015
2021-02-01 01:55:35 | INFO | train_inner | epoch 020:   1159 / 1334 loss=2.045, nll_loss=0.194, ppl=1.14, wps=9113, ups=9.8, wpb=930.1, bsz=71.7, num_updates=26500, lr=6.799e-05, gnorm=0.351, loss_scale=8, train_wall=10, wall=3025
2021-02-01 01:55:45 | INFO | train_inner | epoch 020:   1259 / 1334 loss=2.051, nll_loss=0.199, ppl=1.15, wps=9103.4, ups=9.74, wpb=934.5, bsz=70.4, num_updates=26600, lr=6.78621e-05, gnorm=0.376, loss_scale=8, train_wall=10, wall=3035
2021-02-01 01:55:53 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:55:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 5 x 1 ml) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:53 | INFO | fairseq.tasks.translation | example reference: 5 x (1 x 10 ml) vials
2021-02-01 01:55:54 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP should be considered. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:54 | INFO | fairseq.tasks.translation | example reference: The advisability of driving should be considered in these circumstances.
2021-02-01 01:55:54 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP 40 IU/ ml solution for injection in a vial. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:54 | INFO | fairseq.tasks.translation | example reference: Actrapid 40 IU/ ml solution for injection in a vial.
2021-02-01 01:55:55 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP patient should therefore ask other medicines. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:55 | INFO | fairseq.tasks.translation | example reference: The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take.
2021-02-01 01:55:55 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP subcutaneous injection sites. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:55 | INFO | fairseq.tasks.translation | example reference: Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites.
2021-02-01 01:55:56 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP intravenous administration should not be excluded. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:56 | INFO | fairseq.tasks.translation | example reference: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
2021-02-01 01:55:57 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP intravenous administration may also be applied. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:57 | INFO | fairseq.tasks.translation | example reference: Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
2021-02-01 01:55:57 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP injection site reactions such as hives, swelling. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:57 | INFO | fairseq.tasks.translation | example reference: As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
2021-02-01 01:55:58 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy disorders may be associated with administration. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:58 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:55:58 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP hyperglycaemia, dry mouth, vomiting UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:58 | INFO | fairseq.tasks.translation | example reference: Die ersten Symptome einer Hyperglykämie, wie Durstgefühl, verstärkter Harndrang, Übelkeit, Erbrechen, Benommenheit, gerötete trockene Haut, Mundtrockenheit, Appetitverlust sowie nach Aceton riechender Atem, treten in der Regel allmählich über Stunden bzw. Tage auf. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
2021-02-01 01:55:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP intravenous glucose occurs with UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:55:59 | INFO | fairseq.tasks.translation | example reference: 5 Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
2021-02-01 01:56:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in type 1 patients. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:56:00 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:56:00 | INFO | valid | epoch 020 | valid on 'valid' subset | loss 8.694 | nll_loss 7.606 | ppl 194.84 | bleu 11.66 | wps 641.9 | wpb 361 | bsz 12.6 | num_updates 26675 | best_loss 3.813
2021-02-01 01:56:00 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:56:16 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_8/checkpoint_last.pt (epoch 20 @ 26675 updates, score 8.694) (writing took 16.56911726295948 seconds)
2021-02-01 01:56:16 | INFO | fairseq_cli.train | end of epoch 20 (average epoch stats below)
2021-02-01 01:56:16 | INFO | train | epoch 020 | loss 2.046 | nll_loss 0.194 | ppl 1.14 | wps 7793.7 | ups 8.36 | wpb 932.3 | bsz 70.5 | num_updates 26675 | lr 6.77666e-05 | gnorm 0.355 | loss_scale 8 | train_wall 134 | wall 3066
2021-02-01 01:56:16 | INFO | fairseq_cli.train | done training in 3059.6 seconds


###############################################################################
Peregrine Cluster
Job 17762804 for user 's3475743'
Finished at: Mon Feb  1 01:56:25 CET 2021

Job details:
============

Job ID              : 17762804
Name                : EMEA_p_8
User                : s3475743
Partition           : gpu
Nodes               : pg-gpu22
Number of Nodes     : 1
Cores               : 12
State               : COMPLETED
Submit              : 2021-02-01T01:03:29
Start               : 2021-02-01T01:04:27
End                 : 2021-02-01T01:56:25
Reserved walltime   : 23:55:00
Used walltime       : 00:51:58
Used CPU time       : 00:54:09 (efficiency:  8.68%)
% User (Computation): 78.86%
% System (I/O)      : 21.14%
Mem reserved        : 32G/node
Max Mem used        : 5.62G (pg-gpu22)
Max Disk Write      : 40.96K (pg-gpu22)
Max Disk Read       : 2.30M (pg-gpu22)
Average GPU usage   : 66.9% (pg-gpu22)


Acknowledgements:
=================

Please see this page for information about acknowledging Peregrine in your publications:

https://wiki.hpc.rug.nl/peregrine/introduction/scientific_output

################################################################################
